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ABSTRACT 
 
Arginine rich cell-penetrating peptides are short cationic peptides capable 
of traversing the plasma membranes of eukaryotic cells.  While successful 
intracellular delivery of many biologically active macromolecules has been 
accomplished using these peptides, their mechanisms of cell entry are still under 
investigation. Ionic interactions between the highly cationic peptides and the 
anionic cell membrane and other anionic molecules on the cell surface are 
believed to be the initial step in the internalization process.  
We examined the interactions of TAT peptide with prototypical cell 
membranes using confocal microscopy and synchrotron small angle x-ray 
scattering (SAXS) and studied the effect of membrane charge and intrinsic 
curvature. We find that the TAT peptide induces negative Gaussian (‘saddle-
splay’) membrane curvature, which is topologically required for pore formation. 
TAT peptide drastically remodels vesicles into a porous ‘sponge-like’ 
bicontinuous manifold. By applying ideas from coordination chemistry, soft 
condensed matter physics and differential geometry, we propose a geometric 
mechanism facilitated by both electrostatics and bidentate hydrogen bonding.  
We also examined the interactions of other arginine rich cell-penetrating 
peptides, including Antp and oligoarginine, with model cell membranes, and find 
that the transduction activity correlates with induction of negative Gaussian 
curvature. The negative Gaussian membrane curvature is broadly enabling and its 
 ii
induction can lower the free energy barriers for a range of different entry 
mechanisms, such as direct translocation as well as endocytotic pathways. 
Furthermore, we show that the TAT peptide interacts strongly with actin 
cytoskeleton, which enhances membrane deformation and cytoskeleton 
reorganization necessary for endocytotic processes.  We propose a mechanism 
that explains how a relatively simple molecule, like the TAT peptide, facilitates 
direct entry and multiple endocytotic mechanisms. 
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CHAPTER 1 
INTRODUCTION 
All cells, in both eukaryotic and prokaryotic organisms, are surrounded by 
the ‘plasma’ or ‘cell’ membrane. This membrane compartmentalizes the 
intracellular space dividing it into two sub-spaces: the lumina of the various 
organelles and the cytosol. This enables the individual compartments to specialize 
for one or several well defined functions creating order within the cell and 
facilitating the control of such a complex machine. The plasma membrane of 
animal cells is in general a three layered compound system (Fig 1.1) [1-3]. The 
center consists of a liquid crystalline lipid/protein layer. The outer surface (called 
the glycocalix) is covered by a macromolecular film formed by the 
oligosaccharides of the glycolipid head groups and the branched 
polypeptide/oligosaccharide head groups of the glycoproteins. At the intracellular 
side, the bilayer couples to the membrane associated cytoskeleton - the three 
dimensional macromolecular network of actin filaments in most cells. In cell 
membranes, lipid bilayers provide a fluidic matrix in which membrane proteins 
move around [4,5]. The lipid bilayer together with the glycocalix forms a 
selective filter which controls the transfer of ions, molecules, molecular 
aggregates and even large particles (such as viruses, bacteria or other cells) 
between the extracellular space and the cytosol. The bilayer is a multifunctional 
system which can simultaneously be the site for energy producing processes (such 
as glycolysis) and for the hormone signal transduction and amplification. The 
glycocalix acts as receptor for extracellular signals and mediates the 
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communication between the cell interior and its environment. The lipid protein 
bilayer together with the cytoskeleton is responsible for the unique combination 
of flexibility and mechanical stability of cells.  The composition of cell 
membranes involves about a hundred components and thus poses a real challenge 
for the development of new concepts of the physical basis of self-organization of 
multi-component systems. However, by reconstituting model membranes from a 
few lipids and membrane proteins, specific membrane function can be studied on 
a molecular level [1]. 
 
 
 
 
 
 
 
 
 
Figure 1.1: Schematic showing the three-layered structure of the cell membrane. 
The lipid/protein bilayer forms the center. The glycocalix faces the 
extracellular side and the cytoskeleton, coupled to the bilayer, faces 
the cytosol. (image adapted from reference [1])  
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1.1 Structure of lipids 
Lipid bilayers are non-covalent structures spontaneously formed by lipid 
molecules due to their amphiphilic nature, that is, they contain a polar region 
(hydrophilic headgroup), which prefer high dielectric constant (polar) solvents 
such as water, and hydrocarbon regions (hydrophobic tails), which prefer non-
polar solvents such as oil.  The hydrophobic tail is generally composed of one or 
two fatty acid chains, whereas the head group varies depending on the type of 
lipid.  The various lipids composing the cell membrane can be divided into two 
main subgroups: one where lipids have a predominantly structural role and other 
where they play a functional role. 
 
The lipids belonging to the first subgroup are (1) cholesterol, (2) the four 
major classes of phospholipids: phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylserine (PS) and sphingomyelin 
(SPHM) and (3) cerebrosides, which are analogs of sphingomyelin with the 
phosphocholine group replaced by non-charged sugars such as galactose or 
glucose. 
 
The second subgroup contains (1) phosphatidylinositol as precursor of the 
2nd messengers based on phosphoinositols, (2) phosphatidic acid and 
phosphatidylglycerol (e.g., as intermediates of lipid synthesis) and many types of 
gangliosides (a member of the cerebrosides) functioning as carriers of blood 
group antigens [1-3]. 
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From the physical point of view lipids are characterized by three structural 
features: 
• the size and electrical property of the head groups, which may be charged (as 
PI, PS, sulfolipids and some gangliosides), zwitterionic (as PC, PE, SPHM) or 
neutral (as cerebrosides or galactosides) 
• the number of carbon atoms (varying between 16 and 24 for the most 
abundant fatty acids) and the number of double bonds (ranging from 1 to 6) 
• the structural difference between the two alkyl chains of each lipid 
 
Phospholipids contain a phosphate group embedded in its molecular 
backbone.  Depending on the alcohol backbone which connects the hydrophobic 
tail to the hydrophilic head group, phospholipids are classified into two groups: 
phosphoglyceride constructed from glycerol, and sphingomyelin derived from 
sphingosine.  Phosphoglycerides are the principal type of phospholipids found in 
cell membranes.  Structures of phosphoglycerides have a common backbone: 
glycerol-3-phosphate.  The other two hydroxyl groups at 1 and 2 positions on 
glycerol are esterified to the carboxyl groups of two fatty acids, which form the 
hydrophobic moiety of the phospholipid.  Besides being connected with glycerol 
in the backbone, the phosphate group forms a second ester bond with another 
alcohol, which constructs the hydrophilic head group of the phospholipid 
 
 Depending on the alcohol in the hydrophilic head group moiety, the 
phospholipids can achieve different properties, such as head group size and 
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charges.  Five alcohols are commonly found in phospholipids present in cell 
membranes: serine, glycerol, inositol, choline, and ethanolamine.  The structures 
of these alcohols are shown in figure 1.2.  If the head group of a phospholipid has 
one serine, glycerol, or inositol attached to its phosphate, the net charge of head 
group is -1 at physiological pH.  When either ethanolamine or choline is esterified 
to the phosphate, the resultant phospholipid, namely phosphatidylethanoamine or 
phosphatidylcholine, is zwitterionic with zero net charge at physiological pH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Alcohols commonly found in head groups of phospholipids present 
in cell membranes. The hydroxyl group in red marks possible 
positions in the alcohols where an ester bond can be formed with the 
phosphate group (image adapted from reference [2]). 
 
In table 1.1 the lipid compositions of plasma membranes and some 
intracellular organelles are summarized.  We can see from the table that the 
phospholipids represent greater than 50 weight % of the total lipid mass in most 
cases, although their relative compositions vary depending on the type of cell.  
The content of charged lipids is roughly 10 mole % in all membranes and is 
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highest in the plasma membranes (11–13%).  The plasma membranes of 
mammalian cells have a high content of cholesterol which amounts roughly to 20 
weight % of the total lipid [1,6]. 
 
Table 1.1: Major lipid components of selected biomembranes (source [7]) 
 
 
 
 
 
 
The lipid bilayer provides a fluidic matrix in which individual lipid 
molecules and membrane proteins can move laterally [4].   The lateral diffusion in 
lipid bilayers can be detected with techniques like fluorescence recovery after 
photobleaching (FRAP) [8,9], single particle tracking (SPT) [10-12], and  optical 
laser trapping [13].  The diffusion of lipid molecules depends on the host bilayer 
instead of the lipid probe itself with a diffusion coefficient of 10-8~10-7 cm2/sec 
[14,15].  The lateral diffusion of integral membrane proteins, on the other hand, 
depends on the protein itself [5,16].  Some proteins are as mobile as lipid 
molecules with diffusion coefficients on the order of 10-8 cm2/sec [16,17], 
whereas others are much slower (diffusion coefficient ~ 10-12 ~10-11 cm2/sec) or 
may even stay stationary [5,18].  In addition to lateral diffusion, lipid molecules 
and membrane proteins may have rotational motion along the molecular axis 
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perpendicular to the bilayer plane or librational motion (wobbling) [19-21].  
However, neither rotation nor wobbling is as important as lateral diffusion for 
biological systems.   
 
Although, lipid molecules can diffuse rapidly in the plane of membrane, it 
is very hard for them to transverse spontaneously from one leaflet to another.  
This motion is called “passive transverse diffusion” or “flip-flop”.  In both 
artificial and living animal cell membranes, unassisted flip-flop of a lipid 
molecule from one leaflet to the other occurs once in several hours or even several 
days [22,23].   However, higher rates of facilitated transmembrane movement of 
lipid molecules have been detected in both living cells and reconstituted 
membranes [24-26].   
 
The fluidity of the lipid bilayer depends on the temperature and properties 
of the composing lipids.  In the “fluid” liquid crystalline phase (Lα), the fatty acid 
chains are in a relatively flexible and disordered state.  If the fatty acid chains are 
in a rigid and ordered state, the lipid bilayer is in a “gel phase” (Lβ).  The 
transition from gel phase (Lβ) to the fluid phase (Lα) occurs abruptly at a 
characteristic temperature, Tm, called the “phase transition temperature” of lipid.  
Generally, for lipids with same head groups but different lengths of saturated fatty 
acid chains, those with longer chains tend to have higher Tm.  For example, 1,2-
Dilauroyl-sn-Glycero-3-Phosphocholine (DLPC) with 12 carbon atoms in the 
fatty acid chain has its Tm at -1ºC; while for 1,2-Distearoyl-sn-Glycero-3-
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Phosphocholine (DSPC), with 18 carbon atoms, the Tm increases to 55ºC [27].  
Also, for lipids with same length of fatty acid chains, introduction of one or two 
carbon-carbon double bonds (CH=CH), especially those of cis- configuration, into 
the chain makes the chains more disordered and greatly decreases the phase 
transition temperature Tm.  For example, 1,2-Dioleoyl-sn-Glycero-3-
Phosphocholine (DOPC), with the same chain length as DSPC but one CH=CH 
bond in cis-configuration in each chain, has a Tm of -20ºC, well below that of 
DSPC [27,28].   
 
 
 
 
 
 
 
Figure 1.3: Schematic representation of gel-liquid phase transition of lipid 
membrane (Cartoons are adapted from reference [29]). 
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1.2 Polymorphism of lipids in aqueous solution  
  When dispersed in aqueous media, surfactants like lipid molecules tend to 
organize such that their hydrophilic headgroups stay in contact with the polar 
solvent while their hydrophobic tails stay in contact with air or other hydrophobic 
molecules.  At low concentration, the surfactant molecules migrate to the air-
water or oil-water interface to lower the interfacial tension.  Depending on the 
solubility of the surfactant, they can also exist in monomeric form in bulk 
solution.  As the concentration of the surfactants is increased, the available 
interfaces become saturated and the interfacial tension becomes a constant.  The 
surfactant molecules no longer migrate to the interface, instead, they self-
assemble in the solution to form aggregates.  The concentration that leads to the 
onset of aggregation is called the “critical micelle concentration” (CMC) [30]. 
 
 Above the CMC, the surfactant molecules form various equilibrium 
phases that coexist with the critical micellar concentration of monomer surfactant 
molecules in the solution.  The CMC for a double-chain zwitterionic phospholipid 
is very low (~ 10-10 M) while single chain surfactant have higher CMC values 
[31].  The driving force behind the aggregation of lipids is the hydrophobic effect 
and the hydrophobic energy is directly proportional to the area of the 
hydrocarbon-water contact.  Thus, the extent of chain-water contact is minimized 
by forming closed aggregates thereby reducing the chemical potential of the 
hydrocarbon chains.   
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 The hydrophobic effect by itself favors complete phase separation of the 
lipid from water.  However, the requirement that the hydrophilic headgroups 
remain in contact with water forces the system to form aggregates such that the 
headgroups form a continuous interface between water and the hydrophobic tails.  
For an aggregate composed of N lipids to be in equilibrium with lipid monomers 
in a binary lipid-water system, the chemical potential of the monomeric and 
aggregated lipids must be equal: 
µ°N + kT/N ln(XN/N) = µ°1 + kT/N lnX1 
where, µ° is the free energy per molecule and X is the mole fraction.  This 
assumes that there are no interactions between the aggregates and monomers.  
When the aggregates are very large (N → ∞), the equation reduces to: 
µ°N ‒ µ°1 = kT ln(CMC) 
which relates the free energy of micellisation to the CMC.  The distribution 
function of the aggregate size is given by: 
XN = N · X1N exp(‒N(µ°N ‒ µ°1)/ kT) 
The variation of µ°N with N dictates the aggregation behavior with lowering of 
µ°N as N increases being a necessary condition for aggregation [30-32]. 
  
  Formation of lipid aggregates is energetically driven by hydrophobic 
effect, which segregates the hydrocarbon chains away from contact with water.  
The structures of lipid aggregates are not always the same, even though their 
formation is due to the same driving force.  One successful approach for 
understanding the polymorphism of lipid aggregates is “geometric packing” 
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[30,33].  According to this model, each aggregate is composed of two well-
defined regimes: (1) a hydrophobic core that contains the hydrocarbon tails, 
packed such that the monomer density is uniform and liquid like, and (2) a surface 
region that contains the polar headgroups surrounded by solvent molecules.  The 
two regions are separated by a well-defined interface.  The free energy per 
molecule of the aggregate is the combination of a surface term fh(g), from the 
headgroup region and a core term ft(g), from the hydrocarbon tail packing.  The 
surface term fh(g) contains contributions from the interfacial tension due to 
headgroup-headgroup, headgroup-solvent, headgroup-hydrocarbon and 
hydrocarbon-solvent interactions.  These interactions include the steric, 
electrostatic, hydration, hydrogen-bonding and van der Waals interactions.  A 
simple approximation for fh(g) is: 
fh(g) = γ · A + (C/Aʹ)  =   γ · (A + (Ah2 / Aʹ)) 
where, C is a constant, γ is the effective interfacial tension of the water-
hydrocarbon interface, A is the area per lipid molecules at the interface, Aʹ is the 
area per molecule at the center of the headgroup repulsion and Ah is the value of 
A which minimizes the fh for a planar layer.  When A = Ah the effective surface 
tension of the flat lipid film vanishes.  This is called the Schulman-Montangne 
condition [34].    
 
 The tail term ft accounts for all the interactions between chain segments 
inside the hydrophobic core.  As described by Israelachvilli and coworkers 
[30,35,36], ft(g) is a constant, independent of geometry if the chains are volume 
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incompressible, no chains protrude into the aqueous exterior and no part of the 
interior of any aggregate is further away from the hydrocarbon-water interface 
than a critical length, lc = lmax, the all-trans chain length. 
 
 For a lipid with hydrophobic carbon tail volume (v), critical hydrocarbon 
chain length (lc), and the hydrocarbon-water interfacial area per molecule (A), a 
dimensionless “packing parameter” p = (v / A · lc) was proposed to understand or 
predict the most favored geometry aggregates of that lipid could adopt.   In the 
absence of interactions between aggregates, value of the packing parameter p can 
predict the preferred geometry as shown in table 1.2 [31,35]. 
 
Table 1.2: Preferred geometries for different values of the critical packing 
fraction 
 
Packing fraction (p) Preferred geometry 
0 – 1/3  spheres 
1/3 – 1/2 cylinders 
1/2 – 1 bilayers 
 
 
In this model, the structure of the self-assemble aggregate is determined 
completely by the relative sizes of the hydrophilic headgroups and the 
hydrophobic tails.  While this model is extremely useful in understanding the 
geometry of lipid aggregates, it has two major limitations.  It is unable to predict 
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the formation of the bicontinuous cubic phases found in many lipid aggregates.  
Also, it cannot interpret the structure of multi-component lipid aggregates.  The 
major defect of this system is that it completely ignores the effect of geometry.  In 
fact, the free energy contribution of both the headgroup and the hydrocarbon tail 
regions depend on the interfacial curvature [31].   
 
 In an alternate approach, lipid monolayers are used as the building blocks 
for lipid aggregates and two coupling lipid monolayers influence each other 
strongly to achieve a balance which determines the final structure lipid aggregates 
adopt [37-39].  If a membrane were constrained to lie on a surface, the only 
relevant energy would be due to changes in the average area per molecule of the 
membrane.  However, the membrane can also deform in the normal direction.  
These out of plane deformations are known as bending or curvature deformations 
and the free energy associated with them is called the curvature free energy [37].  
For a membrane with finite thickness, pure curvature deformations are those 
perturbations that do not change the overall membrane volume but there may be 
local stretching and compressions.  Also, for membranes of finite thickness, a 
surface that undergoes no stretching or compression can be chosen to define the 
interface.  The choice of this surface depends on the various elastic constants of 
the system and is system dependent except for perfectly symmetrical membranes.  
However, for membrane deformations with wavelengths larger than the 
membrane thickness, the exact position of the interface is not crucial.   
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 For a point on a surface in the three dimensional space, we can define a 
‘normal’ curvature for all the curves on that surface passing through that point.  
The two principal curvatures, c1 and c2, are the maximum and minimum 
curvatures among all the normal curvatures going through that point and are 
perpendicular to each other. The topology of the surface is usually characterized 
by its mean curvature H and Gaussian curvature K, which are defined as 
( )212
1 ccH +=
 
21 ccK ⋅=  
The free energy per unit area associated with bending a membrane, as described 
by Helfrich [40], can be written as  
                        
2
kf = (c1 + c2 – 2c0)2 + G c1 c2 k
The mean curvature which minimizes the free energy, c0, is called the 
‘spontaneous curvature’ of the membrane.  The ‘bending modulus’, k, is the 
energy cost of deviating from the spontaneous curvature and the ‘saddle-splay 
modulus’, kG , measures the energy cost of saddle like deformations. 
 
The shape of the lipid molecules determines the spontaneous curvature.  
For c0 < 0, the lipids are shaped like traffic cones, with small head groups and 
bulky tails, and tend to bend toward the hydrophilic side.  For c0 > 0, the lipids are 
shaped like ice-cream cones, with bulky head groups and small tails, and tend to 
bend toward the hydrophobic side.  A ‘cylindrical’ lipid, whose hydrophilic head 
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and hydrophobic tail span the same area, will have zero spontaneous curvature, 
and form flat bilayers. 
 
Different phases have different values of mean and/or Gaussian interfacial 
curvatures, and these may or may not be uniform at different points on the 
interface within a single phase.  The Gaussian curvature K is a more fundamental 
property of the interface than H since it determines the qualitative nature of the 
surface.  Surfaces for which K is positive are known as elliptic, and naturally bend 
round to form closed shells.  Micelle or inverse micelles are examples of this.  
When either of the principal curvatures are zero, the Gaussian curvature is zero, 
and the surface is known as parabolic.  The lamellar and hexagonal phases are 
examples of this.  The third possibility arises when the principal curvatures c1 and 
c2 are of opposite sign, leading to a negative Gaussian curvature.  These surfaces 
are known as hyperbolic, and an example is the saddle surface.  The Gaussian 
curvature is most negative at the saddle point and increases smoothly to zero at 
the four apices. When the principal curvatures are everywhere equal in magnitude 
but opposite in sign, then the surface has zero mean curvature at all points but 
negative Gaussian curvature.  Examples of these are the bicontinuous cubic 
phases.  Figure 1.4 gives a summary on mean curvature and Gaussian curvature of 
several structures commonly observed in lipid systems [41]. 
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Figure 1.4: Mean curvature H and Gaussian curvature K of structures commonly 
observed in lipid systems (Image adapted from references [42,43]). 
 
 
1.3 Cubic phases in lipids 
The cell membrane contains many lipids that promote the formation of 
non-lamellar phases, including cubic phases.  The non-lamellar phases can be 
subdivided into two types.  A type I phase denotes a phase whose structure 
elements are filled by the apolar moiety and are embedded in a polar matrix (i.e.  
oil-in-water), whereas a type II phase denotes the reverse (i.e.  water-in-oil).  
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Lipid cubic phases can be sorted in two main classes: 'bicontinuous' and 
'micellar’.  The bicontinuous phases of type II can be visualized in terms of a 
highly convoluted lipid bilayer, which subdivides 3D space into two disjointed 
polar labyrinths separated by an a polar septum.  Bicontinuous phases of type I 
are also known, in which the septum and the two labyrinths are filled by the polar 
and the non-polar medium, respectively.  The bicontinuous cubic phases of type II 
partition 3D space into two distinct and disjointed polar compartments (an inside 
and an outside) separated from each other by a hydrophobic septum.  In lipid-
water systems, six cubic structures have been found, Q212, Q223, Q224, Q227, 
Q229 and Q230.  Of these only the Q224 and Q227 phases are stable in the 
presence of excess water, which is the case for biological membranes [41,44,45]. 
 
It has been hypothesized that the bicontinuous cubic phases are based 
upon underlying periodic minimal surfaces (surfaces that have zero mean 
curvature at all points) [46-50].  The basis of this is that parallel surfaces on either 
side of a minimal surface have smaller areas, and hence have non-zero average 
mean curvatures, directed away from the minimal surface.  A lipid bilayer draped 
onto such a minimal surface will have a net curvature of each monolayer towards 
the water regions.  Thus a system which has a preferred area per headgroup which 
is smaller than the preferred area per chain(s) can lower its elastic energy by 
deforming from a planar bilayer to a saddle surface [41].  A minimal surface can 
be represented (locally) by a set of three integrals called the Wierstrass integrals 
in which the coordinates of a minimal surface patch is described as integrals of a 
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complex valued function.  It involves two mappings.  First the normal direction of 
each point on the surface is plotted on a unit sphere.  This is the Gaussian 
mapping.  These points are subsequently stereographically projected onto an 
equatorial plane.  Under these operations, the minimal surface is transformed into 
a multi-sheeted covering of the complex plane.  Any point on the minimal surface 
(except fiat points), characterized by cartesian coordinates (x,y,z) is described by 
the complex number ω, which defines its mapped location in the complex plane.  
The Weierstrass equations allow calculation of the cartesian coordinates ((x,y,z) 
with respect to an origin (xo,yo,zo)) of the minimal surface at all points on the 
surface - except flat points - in terms of a complex analytic function R(ω).  The 
Weierstrass equations are: 
x = x0 + Re eiθ (1 – ω2) R(ω) dω ∫ 10ωω
y = y0 + Im  eiθ (1 + ω2) R(ω) dω  ∫ 10ωω
z = z0 - Re  eiθ (2ω) R(ω) dω ∫ 10ωω
Integration is carried out on an arbitrary path from ωo to ω1 in the complex plane, 
for a fixed value of θ between 0 and π/2.  Any analytic function R(ω) can be 
plugged into the equations, to give a minimal surface.  Further, the function R(ω) 
uniquely determines a family of surfaces related by the Bonnet transformation as 
θ varies.  This means that one surface can be transformed into either of the others 
simply by bending, which leaves the Gaussian curvature at all points unchanged, 
and preserves all angles, distances and areas on the surface.  In terms of minimal 
surfaces, the inverse bicontinuous cubic phases Ia3d, Pn3m and Im3m are formed 
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by draping a continuous lipid bilayer onto the G-, D- and P-minimal surfaces, 
respectively.  The D surface has θ = 0°, the G surface has θ = 38.015° and the P 
surface has θ = 90° [44,45].   
The Ia3d (= Q230) cubic phase consists of two interwoven yet 
unconnected chiral networks of water/lipid cylinders, connected coplanarly three 
by three and separated by the G-minimal surface (Fig 1.5a).  Although the two 
networks are chiral, the cubic phase itself is centrosymmetric.  The Pn3m (= 
Q224) cubic phase consists of two interwoven tetrahedral networks of water 
channels arranged on a double-diamond lattice, separated by the D-minimal 
surface (Fig 1.5b).  The Im3m (= Q229) cubic phase has orthogonal networks of 
water channels connected six-by-six, and separated by the P-minimal surface (Fig 
1.5c) [41,49,51]. 
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ba) 
 
 
c)  
 
 
 
 
 
 
Figure 1.5: Schematics of the inverse bicontinuous cubic phases:  
a) Ia3d (= Q230); b) Pn3m (= Q224); c) Im3m (= Q229). 
(image adapted from reference [41]) 
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1.4 Characterization of lipid phases 
An understanding of lipid mesomorphism begins with determination of the 
structures of the phases.  X-ray and neutron diffraction, being directly sensitive to 
the time-averaged arrangement of molecules within a specimen, have yielded 
much of the known information about lipid phase structure [52-56].  Diffraction is 
also one of the least ambiguous methods for phase assignment in lipid systems.  
Freeze-fracture electron microscopy, when used in conjunction with X-ray 
diffraction, can yield useful complementary data [57].  In the characterization of 
lipid mesophases by diffraction, there are two regions of the diffraction pattern 
that are used to identify the phase.  The small angle region identifies the 
symmetry and long range organization of the phase, whereas the wide angle 
region gives information on the molecular packing, or short range organization of 
the phase.  The signature of a translationally ordered mesophase is the appearance 
of one or more sharp (Bragg) peaks in the low-angle region of the diffraction 
pattern.   
 
The lamellar phase shows a series of reflections corresponding to 
(dominating) one-dimensional periodicity, and from the X-ray data it is possible 
to determine the thickness of the lipid bilayer, the cross-section per polar head 
group, and the water layer thickness, assuming a specific sheet geometry.  In the 
same way the diameter of the cylinders in the HI and HII phases can be 
determined, as well as the cross-sectional area per polar head group and the 
distance between adjacent cylinders [41,58]. 
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Cubic lipid phases have a very much more complex architecture than 
lamellar and hexagonal phases.  The lattice type can be identified by the 
characteristic ratios of the Bragg reflections.  It is, then, necessary to determine 
the crystallographic spacegroup to which the phase belongs, from the pattern of 
systematic absences in the diffraction pattern.  However, this is often not trivial, 
since usually only a few low-angle Bragg peaks are detected, due to the large 
thermal disorder inherent in liquid-crystalline phases, which strongly damps the 
intensities at larger diffraction angles.  From unaligned samples it is usually only 
possible to identify the cubic aspect from the systematic absences, leaving an 
ambiguity about the precise spacegroup.  The intensities of the various Bragg 
peaks are determined by the distribution of matter (electron density) in the unit 
cell, which is constrained by the symmetry of the spacegroup.  A symmetry-
allowed reflection may nonetheless have zero intensity because the unit cell 
Fourier transform happens to pass through zero at that particular diffraction angle.  
A further major problem with the characterisation of lipid phases is the difficulty 
of ensuring that the sample is at equilibrium.  In part this may be due to the rate at 
which a phase comes to equilibrium being very slow.  However, a further problem 
is that the phase itself may be metastable, reverting to more stable forms over a 
time scale which can span seconds to months [38,41,50,59,60]. 
 
 It has frequently been suggested that transitions to non-lamellar phases 
occur via the formation of defects such as inverse micelles [61-63].  In a model 
developed by Siegel, the first step involves the formation of an ‘inverted micellar 
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intermediate’ between apposed bilayers [64-66].  Two subsequent outcomes are 
possible (in addition to reversion), depending on the particular lipid system (fig.  
1.6).  Either the inverted micellar intermediate can fuse with neighbouring ones to 
form rod-like inverse micelles, or it can fuse with the surrounding monolayers to 
form an ‘interlamellar attachment’, a fusion channel between the two bilayers.  
The former outcome should lead to the formation of the HII phase, whereas the 
latter should lead to the formation of inverse bicontinuous structures such as cubic 
phases.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Proposed routes for inverse bicontinuous cubic and HII phase 
formation, via ‘inverted micellar intermediates’ (image adapted from 
reference [41]) 
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For lipid systems forming inverse phases, it is known that the Lα–HII 
transition occurs with the lamellar (001) planes aligned with the (10) planes of the 
HII phase [67,68].  For the system monooleoyl glycerol, which forms inverse 
bicontinuous cubic phases, the (001) planes of the lamellar phase were found to 
be aligned with the (211) planes of the Ia3d cubic phase although occasional 
alignment with the (220) planes has also been observed [41]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Epitaxial relationships between the lamellar L_, type I cubic Q_ 
(spacegroup Ia3d) and type I hexagonal H_ phases of a 
polyoxyethylene surfactant (image adapted from [41]).  
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1.5 Application of liposomes 
 Liposomes are spherical, self-closed vesicles in which the lipid bilayer 
sequesters part of the solvent into their interior.  Liposomes can be made entirely 
from naturally occurring substances and are therefore nontoxic, biodegradable and 
non immunogenic.  Liposomes can be used as solubilizers for difficult-to-dissolve 
substances, dispersants, sustained release systems, delivery systems for the 
encapsulated substances, stabilizers, protective agents, microencapsulation 
systems and microreactors.  In addition, liposomes can be used use as a model in 
the basic studies of cell interactions, recognition processes, and of the mode of 
action of certain substances.  [69-71] 
 
 Liposomes have proven to be useful drug delivery systems as they offer 
several advantages over conventional dosage methods.  They allow for delivery of 
hydrophobic or amphiphilic drugs that would otherwise be difficult to administer.  
They can be used to isolate a bioactive agent, so as to direct the agent away from 
certain tissues and to deliver the agent to other tissues.  This site-specific targeting 
can be improved by modifying the surface of the liposomes with ligands that bind 
to specific target cells.  In general, liposome encapsulation is considered when 
drugs are very potent, toxic and have very short life times in the blood circulation 
or at the sites of local administration.  [72-76] 
 
 Early liposomal formulations suffered from the fast blood clearance by the 
reticuloendothelial system (RES).  It is now recognized that particle size, surface 
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charge and liposome composition all have strong influences on the clearance 
profile.  [77-79] Liposomes coated with the poly(ethylene glycol) (PEG) have 
significantly increased their circulation half-life in the blood, and revolutionized 
liposome technology.  The PEG ‘shell’ protects the liposomal surface and 
substantially inhibits protein adsorption and opsonization of the liposomes, as 
well as minimizes recognition by the RES system.  [80-83]  
 
 At present, most lipid vesicle mediated bioactive agent delivery is either 
untargeted or passively targeted.  Also, they release the encapsulated agent 
through passive diffusion from the vesicle or through slow, non-specific 
degradation of the vesicles.  These mechanisms can lead to systemic toxicity and 
also lack the ability to accurately deliver the bioactive agent to a specific tissue 
type and/or at a specific time.  It would be desirable to have a lipid vesicle system 
in which the contents of the vesicle are released when the vesicle is in contact 
with a specific environment, such as a specific tissue.   
 
 Antibodies have been used to develop targeted liposome-based delivery 
systems [84-89].  However, antibody conjugations are difficult to control and 
typically show poor site-specificity for the conjugation and inconsistent binding 
affinity.   Furthermore, identifying antibodies against molecules that are inherently 
less immunogenic is difficult.  The use of DNA aptamers as alternatives to 
antibodies can potentially overcome these shortcomings [90].  Aptamers are 
RNAs and DNAs that have high binding-affinities to specific ligands.  Aptamers 
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are identified by in vitro selection experiments (termed SELEX: systematic 
evolution of ligands by exponential enrichment), which, starting from random 
sequence libraries, optimize the nucleic acids for binding to given ligands [91-98].  
Aptamers are unstructured in solution but upon associating with their specific 
ligand fold into molecular architectures in which the ligand becomes an intrinsic 
part of the nucleic acid structure.  Since aptamers are identified through an in vitro 
process that does not depend on animals, cells, or even in vivo conditions, the 
properties of aptamers can be changed on demand.  Aptamers are produced by 
chemical synthesis with extreme accuracy and reproducibility.  As a result 
aptamers for molecules that do not induce an immune response can also be 
identified.  Aptamers have been identified that bind to small molecular targets, 
including metal ions, drugs, antibiotics, nucleotides, and peptides.  [90,99-107] 
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CHAPTER 2 
ARGININE RICH CELL-PENETRATING PEPTIDES 
Cellular uptake of biologically active molecules is a major obstacle in 
pharmaceutical drug design and controlled drug delivery.  While a broad range of 
therapeutic agents, including proteins, peptides and oligonucleotides, have been 
successfully introduced to target cells using viral vectors[1], and methods such as 
electroporation, and microinjection, and liposome encapsulation[2], these 
internalization strategies have a number of drawbacks.  Problems include 
inefficient drug delivery, high variability of drug expression among target cells, 
cellular damage and toxicity, and restrictions based upon drug and cell type.  The 
first barrier to efficient and controlled intracellular delivery is the plasma 
membrane which prevents direct translocation of hydrophilic macromolecules. In 
vivo, the most common pathway for bringing a macromolecule into a cell is 
through endocytosis.  However, the fate of an endocytosed macromolecule is 
unpredictable; it may remain trapped in endosomes and suffer degradation by the 
acidic pH and digestive enzymes. 
 
Biology has evolved ways to circumvent these problems as a number of 
proteins are permeable to mammalian cell membranes.  This ability is conferred 
by a localized region in the protein known as the protein transduction domain.  
Furthermore the isolated peptide sequence, sometimes referred to as a cell-
penetrating peptide, retains the transduction properties of the native protein.  
These cell penetrating peptides comprise a class of short (<20 amino acid) 
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cationic peptides that have the ability to traverse the cell membranes of many 
different types of mammalian cells.  A wide variety of macromolecules have been 
attached to these peptides and subsequently internalized.  Moreover, after uptake 
the cargo maintains its activity.  The ability of cell-penetrating peptides to 
translocate biologically active molecules into cells makes these peptides 
promising candidates for drug delivery applications. 
 
Among the cell-penetrating peptides, the arginine-rich cell-penetrating 
peptides have been the most widely studied[3,4].  Examples include the TAT 
peptide from the HIV transactivator protein TAT, penetratin, a 16 amino acid 
domain from the Antennapedia protein of Drosophila, a flock house virus (FHV) 
coat peptide (sequence 35-49), and oligoarginines [3,5].  The focus here is on the 
TAT peptide, partly because it has attracted the most attention, but also because it 
is a prototypical example that has many of the essential characteristics of the 
arginine-rich cell-penetrating peptides. 
 
2.1 TAT peptide as a prototypical example of arginine rich cell 
penetrating peptides 
 In 1988, Green and Lowenstein [6], and Frankel and Pabo [7], 
independently discovered that the transactivator of transcription (TAT) protein of 
the Human Immunodeficiency Virus can penetrate cells and activate the viral 
genome replication. The TAT protein is an 86 amino acid long protein that is 
released by infected cells and is an essential regulatory gene for HIV replication 
[8]. In 1997, Vives et al [9] found that a 11-amino acid sequence, TAT (47-57), 
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known as the TAT peptide or TAT PTD, can not only enter cells but is more 
efficient than the full length protein. It was observed that the chirality of the 
peptide backbone has no effect on cellular uptake of TAT peptide; inverse and 
retro forms were able to enter cells as efficiently as the native peptide, suggesting 
uptake does not require a specific binding site. The TAT peptide can enter cells 
efficiently, either alone or linked to macromolecules like proteins, 
oligonucleotides or liposomes.  TAT-mediated delivery appears to be independent 
of cargo size.  Proteins in excess of 100,000 Da, 40 nm nanoparticles and even 
200 nm liposomes have been delivered inside cells using TAT peptide. The 
liposomes were intact inside the cells and remained so even 1 hour after 
transduction.  Conversely, non-conjugated proteins in the incubation media were 
not able to enter cells [10].   
 
 TAT peptide is highly cationic with 6 arginine and 2 lysine residues. 
Substitution of any basic residue with neutral alanine reduces activity, while 
substitution of neutral residues has no effect, implying the net positive charge of 
TAT is necessary for cellular uptake.  It has been hypothesized that the utility of 
being positively charged likely comes from the resulting strong electrostatic 
interactions with the plasma membranes of eukaryotic cells.  Studies on the 
binding affinities of cationic cell-penetrating peptides indicate these peptides 
strongly bind electrostatically to the various anionic species present at the 
extracellular surface of cell membranes, including lipid headgroups, proteins like 
nucleolin, and proteoglycans such as heparin sulfate [11,12].   
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 Although electrostatic interactions are known to be important for arginine-
rich cell penetrating peptides, non-electrostatic effects such as hydrophobicity and 
peptide structural transitions can also contribute to the binding affinity of 
amphipathic cell-penetrating peptides to cell membranes [13]. For example, 
penetratin adopts a random coil structure in solution, and transforms to an α-
helical conformation at high lipid to peptide molar ratios [14,15]. Moreover, 
decreasing the lipid to peptide ratio promotes a higher degree of β-sheet 
conformation [15].  Both of these secondary structural transitions increase the 
amphipathicity of Penetratin, allowing its hydrophobic moieties to directly 
interact with the non-polar interior of the lipid membrane, and several studies 
have implicated insertion of the hydrophobic portions of Penetratin into the 
membrane as being important for uptake [16-18]. In contrast, the non-amphipathic 
TAT peptide is unstructured both in solution and when associated with lipid 
membranes [19], and TAT associates with the membrane surface since 
hydrophobic interaction is negligible [11].  
 
 It is empirically known that the cationic nature of the peptide is a 
necessary condition but not a sufficient condition for translocation activity. 
Although, arginine-rich oligomers can enter cells, similar length polymers of 
other basic amino acids, lysine, ornithine or histidine, cannot [20]. Branched 
chain arginine polymer is as efficient as the corresponding linear polymer.  
However, peptide length is an important factor [21].  The efficiency of cellular 
uptake depends on the number of arginine residues.  Arginine polymers with less 
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than five amino acids are not as effective as polymers with six or more amino 
acids. Uptake efficiency increases as the peptide length increases up to 15 amino 
acids. Peptides with more than 15 arginine residues can still enter cells but with 
significantly less efficiency [20,22]. The guanidinium headgroup of arginine is the 
central structural feature required for peptide uptake. Heptamers of citrulline, an 
isotere of arginine with a nitrogen of guanidine replaced by oxygen, are unable to 
enter cells [20]. 
 
 The discovery that the guanidinium residues of arginine are the essential 
ingredients of a peptide’s ability to enter cells has allowed for the design of a 
range of guanidinium-rich synthetic analogs. Oligoarginine peptoids that have the 
side chain attached to nitrogen instead of carbon have proved to be more efficient 
than oligoarginines [21]. Guanidinium-rich oligocarbamates were taken up into 
cells about three times faster than TAT peptide [23]. Polyguanidino dendrimers, 
based on diamino acid monomeric units, have also proven to be effective at 
entering cells [24]. Carbohydrate-based polymers like the guanidinylated 
neomycin can not only enter cells but can carry large (>300kDa) bioactive 
macromolecules along [25]. Recently Deming et al [26] combined liposome drug 
delivery system with cell-penetrating peptides by preparing polyarginine-
polyleucine block copolymers that self-assemble into vesicles. The vesicles 
remained intact inside the cells showing their potential to carry large cargoes. 
Although long polyarginine chains (>20) are thought to be less efficient for 
intracellular delivery, they facilitated cellular uptake of the vesicles.  
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2.2 Mechanism of cellular uptake: direct translocation or endocytosis?  
The exact molecular mechanism of cellular entry of arginine-rich cell 
penetrating peptides is currently not fully understood. Initial studies indicated a 
direct translocation mechanism across the cell membrane that bypassed 
endocytosis. Fluorescence microscopy and fluorescence activated cell sorting 
(FACS) studies on cells incubated with fluorescently-labeled peptides showed 
rapid translocation that was not inhibited when cells were incubated at 4°C. 
Addition of metabolic or endocytosis inhibitors also seemed to have no effect on 
cellular internalization. These experiments, along with the finding that inverse and 
retro forms of the peptide are as effective, led to the belief that cellular uptake 
involved an energy-independent, non-endocytotic process that was receptor 
independent.  
 
 Most of these early experiments were conducted using microscopy or flow 
cytometry on fixed cells. In 2003, Richard et al [27] showed that a mild fixation 
of cells with formaldehyde drastically changed the intracellular distribution of 
TAT peptide. Fixed cells showed nuclear localization of TAT peptide while 
unfixed cells had the peptide located in cytoplasmic vesicles. Additionally, it was 
shown that flow cytometry was unable to distinguish between membrane-bound 
and internalized fluorochrome. In living, nonfixed cells analyzed with FACS, 
large fraction of the fluorescent peptide was associated with the outer leaflet of 
the cell membrane instead of being present within the cytoplasm. They 
demonstrated that trypsin treatment of cells removed surface-bound peptide by 
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digesting the peptide. FACS analysis following trypsin treatment indicated a 
relatively slow rate of uptake, comparable to that of classical markers of 
endocytosis. Since then, many other studies have also observed inhibition of 
cellular uptake at 4°C and with chemical means that induce energy depletion, 
indicating an energy-dependent process as the major route for the internalization 
of cell-penetrating peptides [27-33].    
 
 Many groups have proposed that cell membrane heparan sulfate 
proteoglycans (HSPGs) act as receptors for extracellular TAT uptake. 
Proteoglycans are negatively charged, and are present on the surface of many cell 
types. Thermodynamic studies have shown that TAT binds with significantly 
greater affinity to heparin sulfate than to anionic lipid vesicles [11,12]. That TAT 
can interact with different components of the membrane suggests that multiple 
mechanisms are possible. Moreover, it has been observed that interaction with the 
cell-penetrating peptides results in aggregation of both anionic lipids and 
proteoglycans, which may provide further clues for the nature of the alternate 
mechanisms [34,35].  
 
 Ligands that bind to proteoglycans can be internalized through an 
endocytotic pathway. Both TAT protein and TAT peptide were shown to bind 
strongly to heparin, a sulfated glycosaminoglycan that mimics the heparan sulfate 
proteoglycans [36,37]. It was also demonstrated that addition of heparin and 
dextran, another sulfated glycosaminoglycan, inhibits the cellular uptake of TAT 
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peptide [31,38,39]. Treatment of cells with chemicals that eliminate or cleave the 
HS proteoglycans resulted in a significant decrease in TAT peptide internalization 
[40]. Studies with mutant cells that are unable to synthesize glycosaminoglycans 
showed reduced TAT-mediated transport [39,41,42]. These studies suggest that 
heparan sulfate can act as a receptor for TAT peptide, and constitute an important 
pathway for internalization; however, none of the studies have demonstrated 
complete inhibition of cellular uptake [41]. In addition, polyarginine was able to 
enter mutant cells that have less than 2% of the wild-type level of heparin sulfate 
[25]. This suggests the presence of a heparan sulfate-independent pathway in 
addition to a heparan sulfate-dependent one.  
 
Analysis of peptide uptake by live-cell microscopy has demonstrated the 
involvement of endocytosis in the cellular internalization of the TAT peptide. 
Within the broad classification of endocytosis, there are several possible 
mechanisms of uptake. Studies on TAT peptide uptake in cells with specific 
endocytotic pathways chemically inhibited have yielded mixed results. Clathrin-
mediated endocytosis has been proposed as the primary mechanism of uptake of 
arginine-rich transporters. Clathrin-mediated endocytosis is the major and best-
characterized endocytotic pathway. It involves strong binding of a ligand to a 
specific cell surface receptor resulting in the clustering of the ligand-receptor 
complexes in coated pits on the plasma membrane, formed by the assembly of 
clathrin. The coated pits then invaginate and pinch off from the plasma membrane 
to form intracellular clathrin-coated vesicles [43]. It has been reported that in 
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HeLa cells, labeled cell-penetrating peptides colocalize with transferrin, a 
glycoprotein marker for endocytosis [27,44]. Another study demonstrated that 
TAT uptake in HeLa cells, in the presence of chlorpromazine, a known inhibitor 
of clathrin-mediated endocytotic pathway, resulted in a 50% inhibition of peptide 
uptake, while incubation in a potassium-free buffer resulted in a 40% decrease, 
indicating the involvement of clathrin-dependent pathway [33]. However, other 
studies with fluorescently labeled polyarginine conjugates [30,45] and fusion 
proteins [41,46] showed that it does not colocalize with transferrin. Another study 
with a TAT-avidin conjugate showed only a modest decrease in uptake upon 
treatment with hyperosmolar medium, a condition shown to decrease clathrin-
dependent endocytosis [47].  
 
Caveolin-dependent endocytosis, a lipid raft-mediated form of endocytosis 
has likewise been implicated. Caveolae are small, hydrophobic membrane 
microdomains that are rich in cholesterol and glycosphingolipids. Ligands 
associate with the cell membrane and then become trapped in relatively stationary 
caveolae, which then bud off the membrane and form caveosomes. Cholesterol is 
required for caveolar uptake and drugs that specifically bind to cholesterol perturb 
internalization through the caveolae [43]. TAT-GFP in HeLa cells [46] and in 
CHO-K1 and HL3T1 cells [41] has been shown to colocalize with caveolin-1. 
Both TAT-rhodamine [45] and TAT-GFP [41] complexes have also been shown 
to colocalize with cholera toxin, which is known to proceed through a caveolin-
dependent pathway. However, nystatin, a compound known to inhibit caveolae 
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formation, and filipin III had little effect on the uptake of fluorescently labeled 
TAT into HeLa cells or CHO cells [33]. 
 
A number of research groups have proposed macropinocytosis as the 
mechanism of uptake for cell-penetrating peptides. Macropinocytosis involves the 
formation of large endocytotic vesicles of irregular size and shape, generated by 
actin-driven envagination of the plasma membrane. Macropinosomes have no 
coat and do not concentrate receptors. They vary in size, sometimes being as large 
as 5 µm in diameter [43]. Studies have shown dose-dependent inhibition of TAT 
peptide uptake when cells are pretreated with amiloride, an inhibitor of the 
Na+/H+ exchange required in macropinocytosis, or cholesterol is removed with β-
cyclodextrin [32,48]. Additionally, cytochalasin D, an inhibitor of actin 
polymerization, and the macropinocytosis inhibitor ethylisopropylamiloride have 
been shown to significantly suppress uptake of the arginine-rich peptides into 
HeLa cells [30]. However, Zaro et al [49] reported that delivery of oligoarginine 
in HeLa cells was not inhibited by incubation at 16 °C, or by treatment with 
amiloride indicating a mechanism different from macropinocytosis. 
 
Although the direct translocation mechanism from earlier studies has been 
shown to be an artifact of cell fixation and membrane-associated peptide, studies 
on live, non-fixed cells have indicated the presence of a non-endocytotic 
mechanism of cellular uptake of cell-penetrating peptides. Maiolo et al [50] used 
confocal microscopy to study the cellular distribution of arginine-rich cell-
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penetrating peptides in live cells. They found that the uptake characteristics were 
a mixture of punctate and diffuse staining. Incubating the cells at 4°C eliminated 
most of the punctate staining, indicating that it is due to endocytotic uptake. The 
diffuse staining appeared to be fast and occurred at both 37°C and 4°C, indicating 
a second, non-endocytotic mechanism. The diffuse staining was not due to the 
release of peptide from endosomes as it appeared first and the punctate staining 
later, and it continued to occur at 4°C when endocytosis is inhibited. Several other 
studies have also reported cellular uptake when the cells have been incubated at 
4°C [26,51-53]. It has also been observed that blocking specific endocytotic 
pathways does not affect the ability of TAT peptide to enter cells.  
 
Examination of translocation of arginine-rich cell-penetrating peptides 
across unilamellar vesicles as a model system has revealed a range of behavior.  
Several early studies have indicated that the addition of both TAT peptide [11,54] 
and Penetratin [55,56] do not induce dye leakage and are not directly translocated 
in lipid vesicles composed mainly of zwitterionic PC and anionic PG and PS 
lipids. Membrane potential measurements also indicate that lipid bilayers with 
similar compositions remain intact [34]. Recent results suggest that the lipid 
composition of the target membrane is important for transduction activity. We 
have directly observed TAT peptide entry into giant unilamellar vesicles without 
any endocytotic machinery, provided that the target membranes have negative 
intrinsic curvature lipids (such as those with PE headgroups) at concentrations 
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above a minimum ‘threshold’ concentration [57]. This can also be observed on 
penetratin, which can also traverse lipid bilayers containing PE lipids [58]. 
 
 A number of studies have investigated the question of how cell penetrating 
peptides dissociate from the plasma membrane once they are internalized. For 
example, it has been shown that the arginine-rich peptide, R8W, can strongly 
interact with the anionic cellular cytoskeleton components actin and tubulin, 
leading to aggregation [59]. The TAT peptide also binds to and condenses DNA. 
Moreover, the binding constant for the TAT peptide with DNA is 1-2 orders of 
magnitude higher than for heparin sulfate, leading to the hypothesis that high 
DNA-binding affinity could facilitate the release of cargo after cellular uptake 
[60], by promoting competition for the membrane association of poly-cationic 
peptides. 
 
 The debate on the mechanism of cell penetrating peptides, mostly notably 
TAT, has often been characterized by a type of ‘either/or’ discourse, such as the 
whether direct translocation or some specific form of endocytosis is most 
relevant. Since the cellular uptake of arginine-rich peptides is dependent on a 
variety of factors, including temperature, incubation time, cell type, cargo type 
and size, linkage type and size, [4,61], comparison between different experiments 
have been difficult, and has compounded the controversy surrounding the uptake 
mechanism. It has no doubt been recognized that more than one mechanism may 
be involved in TAT translocation activity. This recognition accommodates the 
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broad range of proposed hypotheses, and can potentially conclude the discourse 
with an artificial consensus. However, an acknowledgement of multiple 
mechanisms of entry does not explain the central phenomenon: How does a 
relatively simple molecule like TAT facilitate mechanisms as different as direct 
entry and the multiple endocytotic mechanisms?  Rather than debate the 
differences between the distinct observed mechanisms, we focus on what these 
different mechanisms have in common, and relate these common features to what 
the physical chemistry of cell penetrating peptides allows them to do.   
 
2.3 Interactions between lipid membranes and biomolecules 
Lipid membrane is a self-assembled structure held together by the non-
covalent interactions between individual lipid molecules. It has two hydrophilic 
surfaces aligned by lipid head groups on each side and one hydrophobic core 
where lipid hydrophobic chains are sequestered from water. In aqueous solution, 
charged lipid membranes and charged biopolymer interact spontaneously through 
two major pathways which are electrostatic interaction and hydrophobic 
interactions. Depending on the structural features of the biopolymer, the 
interactions between lipid membranes and biopolymers can be either dominated 
by electrostatic interaction or a combination of electrostatic interaction and 
hydrophobic interaction. If the biopolymer is a polyelectrolyte, like the TAT 
peptide, the membrane-polyelectrolyte interaction is dominated by electrostatic 
interactions and, in their self-assembled structure, the polyelectrolyte molecules 
are associated with the hydrophilic surface of lipid membranes and do not insert 
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into membrane’s hydrophobic region. If the biopolymer is amphipathic with well 
separated hydrophilic and hydrophobic domains, both electrostatic and 
hydrophobic interactions contribute and the resultant structure formed by 
membrane and biopolymer has biopolymer molecules either partially embedded 
or completely spanning the membrane’s hydrophobic core. 
 
2.3.1 Electrostatic interactions between lipid membranes and 
polyelectrolytes 
Electrostatics in aqueous environments is counterintuitive. At 
physiological conditions, electric fields from charged biopolymers are strongly 
reduced by the large dielectric constant of water and by screening from ions from 
dissociated salts. That is not to say that electrostatic interactions are weak. The 
entropy of ions can result in strong interactions between charged objects in water 
despite short screening lengths, via coupling between osmotic and electrostatic 
interactions. For example, the attraction between a cationic cell penetrating 
peptide and an anionic membrane is driven by the entropy gain from release of 
condensed counterions. 
 
According to Manning’s theory for linear polyelectrolyte solution, the real 
polyelectrolyte is simplified as an infinite line charge with average axial charge 
spacing b and, if its Manning parameter           is larger than one (lB is the 
Bjerrrum length), counterion condensation around the polyelectrolyte chain 
occurs to reduce ξ to a value just less than one [62]. The Bjerrum length lB is 
defined as the length scale where the electrostatic interaction between two unit 
b
lB=ξ
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charges is equal to the thermal fluctuation energy kBT. In a solvent with dielectric 
constant ε, the Bjerrum length lB is 
          2.1 
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where e is the unit charge, kB is the Boltzman constant, and T is the absolute 
temperature. In water at 25ºC, the Bjerrum length lB = 7.1Å.  
 
For a charged plane of infinite size, the counterions condense onto the 
plane to form the Gouy-Chapman double layer independent of the surface charge 
density of the plane [63]. The Gouy-Chapmen length lGC is defined as 
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where ε is the dielectric constant of the solvent, kB is the Boltzman constant, e is 
unit charge, σ is the surface charge density of the plane, and lB is the Bjerrum 
length.  
 
When charged biopolymers are adsorped onto an oppositely charged 
membrane, the complementary charge distributions can electrostatically 
compensate one another. This means that condensed counterions are no longer 
needed by the membrane and the polymer at the regions of contact, and thus can 
be released for a large entropic gain. This leads to a strong electrostatic attraction. 
This type of electrostatic interaction has been observed for self-assembled 
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complexes between membranes and a variety of anionic polymers, including 
DNA [64-66], F-Actin [67], microtubules [68], and filamentous phages [69].   
 
When the surface charge densities of the membrane and the charged 
polymer are similar, as in the case for cationic lipids and DNA complexes, the 
counterion release is nearly maximal. DNA and cationic lipids in aqueous solution 
self-assemble into a lamellar structure where one layer of DNA molecules 
confined between two layers of lipid membranes and distance between DNA 
molecules within the layer depends the lipid-to-DNA mass ratio [70]. If the 
concentration of the negative intrinsic curvature lipids, like DOPE, in the 
membrane is increased, the membrane rigidity decreases and the DNA-membrane 
complexes undergo a phase transition from lamellar to inverted hexagonal 
structures where the membrane wraps around the DNA molecules.  
 
 For complexes of lipids with Filamentous actin (F-actin), a highly charged 
polyelectrolyte found in cellular cytoskeleton, the surface charge densities are 
very different and complete counterion release is sterically impossible. The 
resulting frustration drives the F-actin and cationic lipid membrane complexes to 
self-assemble into network of tubules on macroscopic scale (> 100 μm) in which 
F-actin-membrane form a lamellar structure with one layer of lipid bilayer 
sandwiched in between two layers of F-actin [71].  
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2.4 Small angle x-ray scattering (SAXS) measurements for biomolecular 
samples 
X-ray diffraction is one of the major techniques widely used in the 
determination of material structures. The experiments reported in this thesis have 
used x-ray diffraction to characterize the structure of self-assembled complexes 
formed by phospholipid membranes and biopolymers or their synthetic 
derivatives. These biomolecular systems are different from conventional solid-
state crystalline materials in the following aspects: (1), these biomocular samples 
are often partially ordered, only exhibiting 1-dimensional or 2-dimensional 
periodic density distribution; (2), these systems are usually fluidic and their 
periodic density distributions have considerable contributions from thermal 
fluctuation and static disorder; (3) the length of order in these systems is in the 
scale of 1-100Å, which confines most of the resultant diffraction pattern to the 
small angle region (diffraction angles of a few degrees); (4) the biomolecular 
systems are normally composed of light elements such as carbon, hydrogen, and 
oxygen, which makes their electron density contrast between the constituent 
components very low and thus lead to weak diffraction intensities. Therefore, 
collection of interpretable data from such biomolecular systems requires X-ray 
beam sources with high intensity and high resolution, which can be easily 
satisfied by modern synchrotron source.  
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2.4.1 Fundamental rules of x-ray diffraction 
In the classical description, X-rays are transverse electromagnetic waves, 
where the electric and magnetic fields are perpendicular to each other and to the 
direction of propagation. It is characterized by its wavelength λ, or its 
wavenumber k = 2π/λ. From a quantum mechanical perspective, the X-rays can be 
viewed as a beam of photons, with each photon having an energy ђω and 
momentum ђk. The intensity of the beam is given by the number if photons 
passing through a given area per unit time. When X-rays interacts with a free 
scatterer with charge q and mass m, the scattered intensity Isc at distance R from 
the scatterer is 
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where I0 is the indicent beam intensity, c is the velocity of light, and 2θ is the 
scattering angle [72-74]. Protons and electrons have the same charge but the mass 
of a proton is 1836 times larger than that of an electron. The scattered intensity by 
a proton is, therefore, (1836)2 times smaller than that by an electron. Hence, the 
X-ray scattering pattern is predominantly contributed by the interactions between 
x-rays and electrons and the scattering contrast is due to the electron density 
difference within the system. When electrons scatter X-rays, if the wavelength of 
the scattered wave is the same as that of the incident one, the scattering process is 
called elastic. However, if energy is transferred to the electron, the scattered 
photon has a longer wavelength relative to that of the incident photon, and the 
scattering process is inelastic (also known as the Compton effect). The inelastic 
contribution is mainly due to phonon scattering. As the energy of incident X-ray 
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photons (~104 ev) is significantly larger than that of phonosn (typically < 10-1 ev), 
the energy change is relative negligible compared to energy of the incident beam 
and the scattering is considered to be quasi-elastic. In practice, special setups with 
very high energy resolution (~ 10-3 ev) are required to detect the energy difference 
between incident and scattered photons in inelastic scattering.   
 
In an X-ray diffraction experiment, the detectors usually count the number 
of single photons. The measured intensity, Isc is the number of photons per second 
recorded by the detector.  The differential cross-section )( Ωd
dσ  can be defined as: 
          Ω− dinondperednsXfr )
 
where, σ is the scattering cross-section, dΩ is the solid angle subtend by the 
detector, and incident flux is the incident beam intensity (I0) divided by its cross-
section area (A0). The measured intensity, Isc, is related to the differential cross-
section Ωd
dσ  by 
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From the X-ray scattering theory[72-74], the differential cross-section for 
a system at thermal equilibrium: 
)(|)(|)( 2 qSqfqP
d
d ⋅⋅∝Ω
σ  
where, P(q) is the polarization factor, f(q) is the form factor of the scatterer and  
S(q) is the structure factor for the scatterer lattice. q=ks - ki, is the scattering vector 
which measures the photon momentum transfer (ki and ks are the wavevectors of 
the incident and scattered waves, respectively). For elastic X-ray scattering, the 
scattering vector q is given by: 
d
Sinq πλ
θπ 24|| ==  
where λ is wavelength of the incident X-ray, θ is half of the scattering angle, and 
d is the periodicity of the electron density fluctuation. 
 
The polarization factor P(q) depends on the X-ray source. In a synchrotron 
source, the electrons orbit in the horizontal plane and hence the emitted x-rays are 
linearly polarized in the orbit plane but elliptically polarized when viewed out of 
that plane. So, for synchrotron source, polarization factor P(q) = 1 in the vertical 
scattering plane, while in the horizontal scattering plane where 2θ 
is the scattering angle. For unpolarized X-ray source, the polarization factor 
. For the small angle x-ray scattering ( ), the 
polarization factor is not significantly different from P(q) ~ 1. 
θ2)( 2CosqP =
2/)21()( 2 θCosqP += 0102 <θ
The static structural factor S(q) accounts the geometry of scatterer and 
contains the structural information of the biomolecular system.  
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and, ∫ >+<= )'().('1)( rrrdrVrG ρρ  
G(r) is the density-density correlation function with ρ(r) being the electron density 
distribution of the system.  
The form factor f(q) of the scatterer is the Fourier Transform of its 
electron density. For an atom, , where ro is the Thomson 
scattering length ( Å) and f o(q) is the atomic form factor given by: 
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where ρ(r) is the number density of electron at position r around the nucleus in the 
atom, and z is the total number of electrons in the atom.  
For a molecule, the form factor f mol(q) is  
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where fj(q) is the atomic form factor of the jth atom in the molecule. If |f mol(q)|2 
can be determined experimentally with sufficient values of scattering vectors q, 
the position rj of the jth atom in the molecule can be known. However, even for the 
very intense x-ray beam provided by modern synchrotron sources, the scattering 
length of a single molecule is not sufficient to yield measurable scattering signals 
and the molecules need to be assembled into a crystal.  
For a crystal, the form factor f crystal(q) is 
))()(()( ∑∑ ••−=
n
n
j
j
R
Riq
r
riqmol
jo
crystal eeqfrqf  
 59
where the first term is the scattering amplitude from the basis of molecules or 
atoms contained in the unit cell and is known as “unit cell structure factor” in 
which rj is the position of jth molecule or atom in the unit cell, and the second 
term is a sum over lattice sites and is known as “lattice sum”. All the terms in the 
lattice sum are phase factors located on the unit circle in a complex plane. This 
lattice sum and as a result the crystal’s form factor f crystal is non-vanishing if and 
only if the scattering vector q coincides with a reciprocal lattice vector G which 
satisfies mRG n ×= π2.  where m is an integer. This is the Laue condition for the 
observation of X-ray diffraction. Scattering from a crystal is confined to distinct 
points in the reciprocal space. The scattering signature can therefore be used to 
deduce structural information.  
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CHAPTER 3 
HIV TAT PEPTIDE FORMS PORES IN MEMBRANES BY 
INDUCING SADDLE-SPLAY CURVATURE: POTENTIAL ROLE 
OF BIDENTATE HYDROGEN BONDING 
3.1 Introduction 
The TAT protein transduction domain (PTD) of the Human Immunodeficiency 
Virus (HIV-1) can cross cell membranes with unusual efficiency [1], and has many 
potential biotechnological applications [2-4]. Extant work has provided important clues 
to the molecular mechanism underlying the activity of this peptide, which consists of 11 
amino acids, 8 of which are cationic, and 6 of these are arginines.  TAT PTD synthesized 
with D-amino acids enter cells as efficiently as the native form [5], indicating that the 
mechanism of transduction is receptor-independent, consistent with recent results that 
suggest that the TAT PTD may enter cells through receptor-independent 
macropinocytosis [6]. Substituting any of the PTD’s cationic residues with alanine 
decreases activity, while substitution of neutral residues has no effect [5]. This indicates 
the importance of electrostatic interactions between cationic TAT PTD and anionic 
phospholipid membranes. Recent work has shown that the physics of electrostatic 
interactions can drive a rich polymorphism of self-assembled structures that depend on 
parameters such as charge density [7,8] and intrinsic membrane curvature [9,10]. 
However, although arginine-rich polycations can enter cells, cationic polylysine cannot 
[11]. This shows that electrostatic interactions alone are insufficient for PTD activity and 
that arginine plays a specific, essential role.  
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In this chapter, we use confocal microscopy and synchrotron x-ray scattering 
(SAXS) to study the interaction of the TAT peptide with model membranes at room 
temperature. We find that the transduction activity correlates with induction of negative 
Gaussian (‘saddle-splay’) membrane curvature, which is topologically required for pore 
formation. Moreover, we show that the TAT peptide can drastically remodel vesicles into 
a porous bicontinuous phase with analogs in block copolymer systems [12-14], and 
propose a geometric mechanism facilitated by both electrostatics and bidentate hydrogen 
bonding. The latter is possible for the TAT peptide but not for similarly-cationic, non-
arginated polypeptides. 
3.2 Experimental section 
3.2.1 Peptide synthesis 
The TAT PTD (Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg), Rh-TAT 
(Rhodamine-labeled TAT peptide) and (Lys)8 are synthesized using automated solid-state 
synthesis. 
3.2.2 SUV preparation 
The lipids 1,2-Dioleoyl-sn-Glycero-3-[Phospho-L-Serine] (sodium salt) (DOPS),  
1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC), 1,2-Dioleoyl-sn-Glycero-3-
Phosphoethanolamine (DOPE), and 1,2-Dioleoyl-sn-Glycero-3-[Phospho-rac-(1-
glycerol)] (Sodium Salt) (DOPG) are purchased from Avanti Polar Lipids and used 
without further preparation. Stock solutions of lipids in chloroform are mixed at the 
desired ratios, dried under N2 and desiccated under vacuum overnight. The dried lipids 
are rehydrated with Millipore water to a final concentration of 30 mg/ml at 37 °C 
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overnight. This solution is sonicated and extruded through a 0.2 μm Nucleopore filter to 
make liposomes. TAT PTD and (Lys)8 are dissolved in millipore water at 10 mg/ml. 
Peptides and liposomes are mixed at different peptide-to-lipid molar ratios and salt 
conditions and subsequently sealed in quartz capillaries.  
3.2.3 Synchrotron x-ray scattering 
Small angle x-ray scattering (SAXS) data is collected at Stanford Synchrotron 
Radiation Laboratory (Palo Alto, CA) (BL4–2) and Advanced Photon Source (Argonne, 
IL, BESSRCAT BL-12ID) using 9-keV and 12-keV x-rays respectively. The scattered 
intensity is collected using a MAR-Research (Hamburg) charge-coupled device detector 
(pixel size 79 μm). All experiments are conducted at room temperature. We observe no 
evidence of radiation damage to the samples. Representative samples are re-measured 
after several months to ensure that they are fully equilibrated. Absolute electron densities 
in the unit cell reconstructions are calibrated by using standard measured values for 
typical head groups and terminal methyl groups. 
3.2.4  GUV preparation 
The lipids DOPS, DOPE, DOPC, 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-
Phosphocholine (POPC), and 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphoethanolamine 
(POPE) are purchased from Avanti Polar Lipids and used without further purification.  
Lipids in chloroform solution are mixed in the following weight ratios:  POPC:DOPS 
80:20, DOPE:DOPC:DOPS 20:60:20 and 40:40:20, with the fluorescent membrane dye 
2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-
hexadecanoyl-sn-glycero-3-phosphocholine (BODIPY, purchased from Invitrogen) 
  71
incorporated at 0.5 mol%.   These solutions are desiccated in a glass vial under vacuum 
overnight.  The resulting film is hydrated with 100 mM NaCl solution containing 1%v/v 
glycerol to achieve a lipid concentration of 1 mg/mL, refrigerated overnight, and 
sonicated for 5-10 minutes.  The resulting suspension is deposited in 5 µL drops on glass 
coverslips, dried for 1-2 hours, and rehydrated with 50 µL of 100 mM NaCl solution.  
Vesicles tens of microns in diameter form and adhere to the glass substrate. 
3.2.5  Confocal microscopy 
Leica inverted laser scanning confocal microscopes are used for all imaging.  
Laser lines of 488 nm and 514 nm, respectively, are used sequentially to excite the 
BODIPY membrane dye and the Rhodamine fluorophore of Rh-PTD, which is added to 
the sample in successive 1-10 µL drops of 1.4 mM concentration. All experiments are 
conducted at room temperature. 
 
3.3 Results and discussion 
Cell membranes are composed of lipids that have fundamentally different 
interactions with cationic macroions such as TAT peptide. We examine representative 
model membranes composed of lipids with different charge and intrinsic curvature: 
DOPC (1,2-Dioleoyl-sn-Glycero-3-Phosphocholine)  and DOPE (1,2-Dioleoyl-sn-
Glycero-3-Phosphoethanolamine) have zwitterionic headgroups while DOPS (1,2-
Dioleoyl-sn-Glycero-3-[Phospho-L-Serine] (Sodium Salt)) and DOPG (1,2-Dioleoyl-sn-
Glycero-3-[Phospho-rac-(1-glycerol)] (Sodium Salt)) have anionic headgroups. DOPS 
and DOPC lipids have zero intrinsic curvature (C0 = 0, ‘cylinder-shaped’) while DOPE 
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has negative intrinsic curvature (C0 < 0, ‘cone-shaped’) [15]. Varying the relative 
amounts of these lipids enables us to independently tune the charge density and intrinsic 
curvature of the model membrane.  
We use confocal microscopy to examine interaction of TAT peptide with Giant 
Unilamellar Vesicles (GUVs, diameters 5-30 µm) with no endocytotic machinery. When 
Rhodamine-tagged TAT peptide (Rh-TAT) is applied to the exterior of GUVs with low 
DOPE content (0% and 20%), Rhodamine fluorescence is seen only outside the GUVs 
(Fig 3.1a), indicating that the Rh-TAT has not crossed these membranes. However, when 
Rh-TAT is applied to GUVs with 40% DOPE content, the Rhodamine intensity 
equilibrates across the membrane over tens of seconds (Fig 3.1b, c).  This shows that Rh-
TAT has crossed the GUV membranes, which remain intact (Fig 3.1c). Thus, we see that 
the membrane transduction activity of Rh-TAT requires the presence of a threshold 
amount of DOPE in the membrane. 
 
 
 
 
a) b) c)
 
Figure 3.1: Rhodamine-tagged TAT peptide (false-color red) is applied to the exterior 
of GUVs of different lipid compositions, imaged using confocal 
microscopy.  (a) Rh-TAT never enters PS:PC 20:80 membranes. (b) Less 
than 3 seconds after addition, Rh-TAT remains mostly exterior to 
BODIPY-tagged PS:PC:PE 20:40:40 membranes (false-color green).       
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Figure 3.1 cont.: (c) About 30 seconds later, the vesicle interior has the same brightness 
as the outside, showing that the Rh-TAT concentration has equilibrated on 
both sides of the membrane. 5 µm scale bars. 
 
To elucidate the molecular interactions between the TAT peptide and such PE-
rich membranes, we use synchrotron SAXS to study complexes formed by this peptide 
and DOPS:DOPE 20:80 membranes. Before exposure to TAT peptide, we see a broad 
form factor (Fig 3.2, bottom), as expected for Small Unilamellar Vesicles (SUVs, 
diameters 15-50 nm). After exposure to the PTD (at peptide:lipid molar ratio of P:L = 
1:40), 9 new diffraction peaks are observed (Fig 3.2, middle). The peak positions in q 
show excellent agreement with those expected for a cubic ‘double diamond’ Pn3m phase 
with a lattice constant of a = 15.97 nm (Fig 3a).  The same peaks are also observed (Fig 
3.2, top) in the presence of HEPES buffer at pH 7.4, indicating that this reconstruction 
can occur at physiological conditions. 
Before making the assignment of a cubic phase to the observed diffraction 
pattern, the possibility of phase coexistence was considered. This is especially important 
for cubic phases, from which different subsets of the diffraction peaks can be indexed to 
simpler phases. In the present case, one can generate a model diffraction pattern using a 
coexistence of a lamellar phase (q1 = 1.11 nm-1) and an inverted hexagonal phase (q10 
=0.96 nm-1), except that it misses the peaks at q = 0.54 nm-1 and 0.66 nm-1. This would 
imply a three-phase coexistence for the present three-component system. Since we see 
essentially the same diffraction pattern for different peptide/lipid molar ratios, different 
PS:PE weight ratios, and different temperatures (three degrees of freedom), this 
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coexistence scheme would violate the Gibbs phase rule and hence, is not possible for a 
system at equilibrium.  
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Figure 3.2: SAXS data show that PS:PE 20:80 vesicles (bottom) undergo a topological 
transformation when complexed with the TAT PTD, to form a cubic 
‘double-diamond’ (Pn3m) phase with two non-intersecting networks of 
pores ~11 nm in diameter (middle). Addition of the TAT PTD in the 
presence of HEPES buffer at pH 7.4 results in the same cubic phase (top).   
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Figure 3.3: (a) The agreement between measured peak positions and the corresponding 
Pn3m cubic indexation, qmeas = 2π√(h2+k2+l2)/a (where h, k, and l are the 
Miller indices and a = 15.97 nm is the lattice parameter).  Schematic 
representations of (b) the two non-intersecting networks of water pores 
(blue), and (c) the zero-mean-curvature surface at the midplane between the 
two membrane leaflets (brown). 
  76
The cubic Pn3m is a bicontinuous phase characterized by negative Gaussian 
curvature, threaded with tetrahedral networks of water pores (Fig 3.3b, c). Its presence 
indicates that the initial SUVs have undergone a drastic topological transformation 
[12,13]. The lattice constant indicates that the pores in these structures are ~11 nm in 
diameter.  The effect of the TAT peptide on PE-rich membranes is the generation of 
negative Gaussian curvature, the type of curvature that characterizes the saddle-shaped 
surfaces inside holes of donuts [15].  
Polylysine has the same charge as the TAT peptide but no transduction activity. In 
complexes formed with polylysine and DOPS:DOPE = 20:80 SUVs (peptide:lipid molar 
ratio 1:40), SAXS shows three diffraction peaks with peak positions at the 1: √3 : 2 ratio 
characteristic of the inverted hexagonal phase (HII) (Fig 3.4). This structural assignment 
is confirmed by an electron density profile of the unit cell (Fig 3.5a, b) reconstructed 
from x-ray data via Fourier synthesis. The phases used for the amplitudes at q10, q11, q20 
are (+,-,-), in agreement with those from previous reconstructions on pure lipid HII phases 
[16]. Regions of the lowest electron density (green-blue, ~0.169 e/Å3) correspond to lipid 
hydrocarbon tails, which surround high-density, hexagonally-coordinated circular rims 
(red, ~0.410 e/Å3) corresponding to phospholipid head groups. In turn, these surround 
intermediate-density channels of the HII phase. For the pure PE HII phase, an electron 
density of 0.337 e/A3 is found in these holes, which corresponds well to the electron 
density of water (Fig 3.5c). For the polylysine-induced PS:PE=20:80 structure, the 
electron density in the corresponding region is ~0.286 e/A3, which is consistent with a 
mixture of water and polypeptide (Fig 3.5b). The density profile shows unambiguously 
that the complex is in an inverted hexagonal HII phase with the small (2.0 nm diameter) 
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water channels ‘plugged’ by polylysine, allowing the cationic polylysine to charge- 
compensate the anionic DOPS lipid heads. The x-ray experiments above show that the 
transduction activity of these peptides is correlated to their ability to induce negative 
Gaussian curvature. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: SAXS data for polylysine complexed with (bottom) PS:PE 20:80 and (top) 
PE membranes show peak positions that have the characteristic 1: √3 :2 
ratio for an inverted hexagonal (HII) phase.   
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Figure 3.5: (a) Electron density reconstruction for polylysine complexed with PS:PE 
20:80 membranes. Radial slices of such reconstructions show that the 
electron density (ρ) in the HII channels formed when (b) polylysine is 
complexed with DOPS:DOPE 20:80 membranes is lower than that in (c) 
pure-DOPE HII phase.  
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The TAT peptide exhibits a hierarchy of peptide-lipid interactions with different 
lipid species. The cationic peptide interacts strongly with localized negative charges in 
both anionic (DOPS) and neutral zwitterionic (DOPC) lipids, but does not interact 
directly with DOPE (Fig 3.6).  
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Figure 3.6: SAXS data show that the TAT PTD ‘glues’ together DOPS (middle) and 
DOPC (bottom) membranes into a lamellar phase with the PTD intercalated 
between the bilayers. The native inverted hexagonal diffraction pattern of 
DOPE (top, black) remains unchanged upon addition of TAT PTD (top, 
red). The two diffraction patterns can be superimposed.  
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To identify minimum conditions for Pn3m phase formation, we studied the 
DOPS:DOPE phase diagram as a function of increasing DOPS fraction and peptide:lipid 
(P:L) ratio. A single-phase Pn3m cubic appears at DOPS fractions of 20%-30%, which 
are typical fractions in eukaryotic membranes (Fig 3.7a). Moreover, this occurs for a 
wide range of P:L ratios. Clearly, DOPS as well as DOPE is necessary for the formation 
of the Pn3m cubic phase. We also systematically isolated the effects of membrane 
curvature by investigating tertiary DOPS:DOPE:DOPC membranes at different P:L 
ratios. We varied the DOPE:DOPC ratio while keeping the DOPS concentration constant 
at a typical eukaryotic value of 20%. This varies the intrinsic curvature without 
significantly changing the charge density. The resultant phase diagram (Fig 3.7b) shows 
that a high local concentration of DOPE (70-80%) is necessary for the cubic phase, which 
can be observed for a wide range of P:L ratios (1:20 to 1:80). For 70% DOPE, 
coexistence between the lamellar and cubic phases is observed. This is consistent with the 
observation that TAT peptide requires high DOPE fractions, and suggests that the TAT 
peptide can induce phase separation in order to organize the Pn3m phase.  
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Figure 3.7: (a) Phase diagram of TAT-PTD with PS/PE membranes show that TAT-
PTD cannot induce pure PE to form the Pn3m phase. PS and PE are both 
necessary for the Pn3m cubic phase.  (b) An investigation of self-assembly 
between TAT PTD with tertiary PS/PE/PC membranes allow us to vary the 
intrinsic curvature independently of the charge density, and indicates that a 
high local concentration of negative curvature lipids such as PE (>70%) is 
necessary for the Pn3m cubic phase 
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We believe that these structural trends in TAT peptide toward pore formation, the 
hierarchy of interactions implicit in this trend, as well as the high transduction activity of 
TAT peptide, can be connected with a simple geometric mechanism. Negative Gaussian 
curvature is needed topologically to form pores. The TAT peptide is observed to generate 
negative Gaussian curvature, which indicates that it can simultaneously induce positive 
curvature along one principal direction and negative curvature in the other to make 
‘saddle-shaped deformations [15]. In contrast, polylysine only generates negative mean 
curvature by bending the membrane along one direction to make ‘cylinder-shaped’ 
deformations. These geometric observations, along with the importance of negative-
curvature DOPE lipids for the TAT peptide’s activity and the hierarchy of peptide-lipid 
interactions combine to suggest a possible molecular mechanism for transduction: Strong 
electrostatic interactions allow polylysine to generate negative curvature in mixtures of 
anionic and neutral lipids. This can be seen in the tendency for the membrane sheet to 
wrap the polypeptide in the direction perpendicular to the peptide axis (Fig 3.8a), creating 
an HII phase. TAT peptide is mostly polyarginine; arginine is the most basic of all amino 
acids, because its side chain ends with a guanidinium group.  Structurally guanidinium is 
characterized by a planar Y-shape which acts to delocalize its cationic charge.  The result 
is a moiety with six potential hydrogen bonding sites.  The multiple hydrogen bonding 
abilities as well as its unique shape allow a guanidinium group to direct both electrostatic 
and hydrogen bonding with anionic and polar molecules [17,18].   When arginine 
interacts with phospholipids this takes the form of bi-dentate hydrogen bonding from 
simultaneous association with the phosphates of two lipid head groups (Fig 3.8b). Lysine, 
in contrast, has an amino group which only forms monodentate hydrogen bonds and 
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therefore interacts with the phosphate on a single lipid head group.  We speculate that 
because of this, arginine groups are more efficient than lysine groups in crosslinking 
bulky headgroups of DOPS and DOPC phospholipids. This generates positive curvature 
along the peptide chain’s contour length in addition to negative curvature perpendicular 
to it, thereby creating negative Gaussian curvature (Fig 3.8c). This generation of negative 
gaussian curvature is manifested in the TAT peptide induced cubic Pn3m phase. The 
preferential interaction of the TAT peptide with non-PE lipids suggests that these 
tendencies may be reinforced via local lipid segregation: Repartitioning of DOPE away 
from the peptide can concentrate negative curvature perpendicular to the peptide axis, as 
well as enrich the DOPE content of the inner membrane leaflet not in contact with TAT 
peptide, thereby increasing positive curvature along the peptide axis.  
 
 
 
 
a)  b) c)
 
Figure 3.8: Schematic showing the mechanism by which TAT peptide generates 
negative Gaussian curvature. (a) Strong electrostatic attraction induces the 
membrane sheet to wrap the polypeptide and generate negative curvature in 
the direction perpendicular to the peptide axis. (b) The guanindinium group 
on the arginine forms bi-dentate hydrogen bonds with the phosphates of two 
lipid head groups. (c) Arginines in TAT peptide efficiently crosslink bulky 
phospholipid headgroups. This generates positive curvature along the 
peptide chain’s contour length in addition to negative curvature 
perpendicular to it, thereby creating negative Gaussian curvature  
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3.4 Summary 
The TAT protein of the HIV virus can cross cell membranes with remarkable 
efficiency. Its 11-amino acid protein transduction domain has been shown to deliver 
everything from nucleic acids to proteins to nanoparticles.  Despite the great potential of 
TAT peptide as carrier of proteins, nucleic acids, and other bioactive compounds, the 
precise mechanism of its internalization is not known. Ionic interactions between the 
highly cationic TAT peptide and the anionic cell membrane and other anionic molecules 
on the cell surface are believed to be the initial step in the internalization process. We 
examined the interactions of TAT peptide with prototypical cell membranes using 
confocal microscopy and synchrotron small angle x-ray scattering (SAXS) and study the 
effect of membrane charge and intrinsic curvature. We find that the transduction activity 
correlates with induction of negative Gaussian (‘saddle-splay’) membrane curvature, 
which is topologically required for pore formation. TAT drastically remodels vesicles 
into a porous ‘sponge-like’ bicontinuous manifold.  This ‘double-diamond’ structure has 
two non-intersecting tetrahedral networks of 6nm-diameter water pores that can facilitate 
the direct translocation of most proteins-sized objects, as well as serve as an intermediate 
state for higher order processes such as receptor-independent forms of endocytosis. By 
applying ideas from coordination chemistry chemistry, soft condensed matter physics and 
differential geometry, we propose a geometric mechanism facilitated by both 
electrostatics and bidentate hydrogen bonding. 
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CHAPTER 4 
MECHANISM FOR CELLULAR UPTAKE OF ARGININE RICH 
CELL-PENETRATING PEPTIDES 
 
4.1 Introduction 
 Arginine rich cell-penetrating peptides have proven to be effective carriers for 
intracellular delivery of therapeutic molecules. These peptides are usually short (< 20 
amino acids) and are highly positively charged. Examples include the TAT peptide from 
the HIV transactivator protein TAT, penetratin, a 16 amino acid domain from the 
Antennapedia protein of Drosophila, a flock house virus (FHV) coat peptide (sequence 
35-49), and oligoarginines [1-3]. The guanidinium headgroup of arginine is the central 
structural feature required for peptide uptake. The importance of the guanidinium group 
comes from the fact that it is able to form bidentate hydrogen bonds with the phosphate 
groups on phospholipids [4-6]. A number of guanidinium based synthetic analogs have 
been developed to enhance therapeutic applications. Examples include guanidinium-rich 
oligocarbamates, carbohydrate-based polymers like the guanidinylated neomycin, 
polyguanidino dendrimers based on diamino acid monomeric units, and oligoarginine 
peptoids with side chains attached to nitrogen instead of carbon. Such analogs have 
proven to be more effective at entering cells than natural peptides [7-10]. 
 The exact molecular mechanism of cellular entry of arginine-rich cell penetrating 
peptides is currently not fully understood. The length of the peptide is an important factor 
with the optimum number of arginine residues between 6 and 15. Peptides with more 
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than 15 arginine residues can still enter cells but with significantly less efficiency 
[7,11,12]. Although initial studies indicated a direct translocation mechanism, it was 
proven to be an artifact of cell fixation [13]. A number of different endocytosis 
mechanisms have been proposed including heparin sulfate-mediated endocytosis, 
clatharin-mediated endocytosis and receptor-independent macropinocytosis [13-18]. 
Also, studies on live, non-fixed cells have indicated the presence of an additional non-
endocytotic mechanism of cellular uptake [19-21].  
 The debate on the mechanism of arginine rich cell-penetrating peptides, has often 
been characterized by a type of ‘either/or’ discourse, such as whether direct translocation 
or some specific form of endocytosis is most relevant. Since the cellular uptake of 
arginine-rich peptides is dependent on a variety of factors, including temperature, 
incubation time, cell type, cargo type and size, linkage type and size, comparison 
between different experiments have been difficult, and has compounded the controversy 
surrounding the uptake mechanism [1,22]. It has no doubt been recognized that more than 
one mechanism may be involved in translocation activity. This recognition 
accommodates the broad range of proposed hypotheses, and can potentially conclude the 
discourse with an artificial consensus. However, an acknowledgement of multiple 
mechanisms of entry does not explain the central phenomenon: How does a relatively 
simple molecule like TAT peptide facilitates mechanisms as different as direct entry and 
the multiple endocytotic mechanisms?  Rather than debate the differences between the 
distinct observed mechanisms, we focus on what these different mechanisms have in 
common, and relate these common features to what the physical chemistry of cell 
penetrating peptides allows them to do.   
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4.2 Experimental section 
4.2.1 Peptide synthesis 
The TAT PTD (Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg), RPEG-3 
(Arg-Arg-Arg-Arg-(PEG)3-Arg-Arg-Arg-Arg), RPEG-5 (Arg-Arg-Arg-Arg-(PEG)5-Arg-
Arg-Arg-Arg) and RPEG-27 (Arg-Arg-Arg-Arg-(PEG)27-Arg-Arg-Arg-Arg) are 
synthesized using automated solid-state synthesis. R9 ((Arg)9) and FITC-labeled TAT are 
purchased from Anaspec, Inc. R34, R46 and R60 are provided by Prof. Tim Deming’s lab at 
UCLA. 
4.2.2 SUV preparation 
The lipids 1,2-Dioleoyl-sn-Glycero-3-[Phospho-L-Serine] (sodium salt) (DOPS),  
1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC), 1,2-Dioleoyl-sn-Glycero-3-
Phosphoethanolamine (DOPE), and 1,2-Dioleoyl-sn-Glycero-3-[Phospho-rac-(1-
glycerol)] (Sodium Salt) (DOPG) are purchased from Avanti Polar Lipids and used 
without further preparation. Stock solutions of lipids in chloroform are mixed at the 
desired ratios, dried under N2 and desiccated under vacuum overnight. The dried lipids 
are rehydrated with Millipore water to a final concentration of 30 mg/ml at 37 °C 
overnight. This solution is sonicated and extruded through a 0.2 μm Nucleopore filter to 
make liposomes. TAT PTD and (Lys)8 are dissolved in millipore water at 10 mg/ml. 
Peptides and liposomes are mixed at different peptide-to-lipid molar ratios and salt 
conditions and subsequently sealed in quartz capillaries.  
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4.2.3 Synchrotron x-ray scattering 
Small angle x-ray scattering (SAXS) data is collected at Stanford Synchrotron 
Radiation Laboratory (Palo Alto, CA) (BL4–2) and Advanced Photon Source (Argonne, 
IL, BESSRCAT BL-12ID) using 9-keV and 12-keV x-rays respectively. The scattered 
intensity is collected using a MAR-Research (Hamburg) charge-coupled device detector 
(pixel size 79 μm). All experiments are conducted at room temperature. We observe no 
evidence of radiation damage to the samples. Representative samples are re-measured 
after several months to ensure that they are fully equilibrated. Absolute electron densities 
in the unit cell reconstructions are calibrated by using standard measured values for 
typical head groups and terminal methyl groups. 
4.2.4 GUV preparation 
Giant unilamellar vesicles (GUVs) are prepared using the electroformation 
process. The chamber is prepared by sealing two ITO-coated microscopic glass slides 
with a U-shaped Teflon spacer (~ 0.5 mm thick) in between. This gives a chamber 
volume of about 300 µl. The lipids DOPS, DOPE, DOPC and PEG2k-PE (1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]) are 
purchased from Avanti Polar Lipids and used without further purification.  Lipids in 
chloroform solution are mixed in the following weight ratio:  DOPE:DOPC:DOPS 
50:30:20 with 2% PEG2k-PE, 5% A23187 (Calcium Ionophore, purchased from Sigma) 
and 3% fluorescent membrane dye DiO (3,3'-dioctadecyloxacarbocyanine perchlorate, 
purchased from Invitrogen).   Approximately 15 µl of these solutions is spread onto one 
of the ITO-coated slides and desiccated under vacuum overnight. The swelling solution 
  91
contains G-actin, prepared from a lyophilized powder of rabbit skeletal muscle purchased 
from Cytoskeleton (Denver), in  2 mM citric acid, 10 mM Tris, 100 mM Sucrose (pH = 
8). Rhodamine phalloidin (Rh-phalloidin, purchased from Cytoskeleton) is used to stain 
actin. The electroformation chamber is connected to a function generator and subjected to 
the following cycle: 
10 Hz sine wave:    - 5 min, 0.11 Vpp 
                               - 20 min, 0.93 Vpp 
                               - 70 min, 2.3 Vpp 
4 Hz square wave:   - 70 min, 2.3 Vpp 
Vesicles tens of microns in diameter form and are diluted in 2 mM citric acid, 10 mM 
Tris, 160 mM glucose (pH = 8).  
 4.2.5 Confocal microscopy 
Leica inverted laser scanning confocal microscopes are used for all imaging.  
Laser lines of 488 nm and 514 nm, respectively, are used sequentially to excite the DiO 
membrane dye and the Rhodamine fluorophore of Rh-phalloidin labeled actin. All 
experiments are conducted at room temperature. 
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4.3 Results and discussion 
4.3.1 Arginine-rich cell-penetrating peptides induce negative gaussian curvature 
 We have seen that the TAT peptide induces negative Gaussian curvature and its 
membrane transduction activity is related to the ability to generate such curvature [6]. We 
also examined two other naturally occurring arginine-rich cell-penetrating peptides Antp 
and pVEC [23]. When these peptides are added to 20:80 DOPS:DOPE small unilamellar 
vesicles, the diffraction pattern changes drastically from the initial broad form factor (Fig 
4.1a). The new peaks observed for both Antp and pVEC can be indexed to the same 
Pn3m cubic phase induced by TAT peptide. The lattice constant of the cubic phase 
induced by Antp and pVEC is 15.9 nm and 16.9 nm, respectively. These results suggest 
that the ability to generate negative Gaussian curvature is general for arginine-rich cell 
penetrating peptide.   
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Figure 4.1: (a) SAXS data show that when PS:PE 20:80 vesicles (bottom) are 
complexed with Antp (middle) or pVEC (top), undergo topological 
transformation and form the cubic Pn3m phase. (b) The cubic indexation 
shows that the lattice constants are 15.9nm and 16.9nm for Antp and pVEC, 
respectively. 
 
It is known that the number of arginine residues in polyarginine is important for 
its transduction ability. Polyarginines with less than 5 arginine residues are unable to 
enter cells; while peptides with more than 15 arginine residues can enter cells but with 
significantly less efficiency [11]. We incubated HeLa cells with fluorescently labeled 
peptides with 4, 9, 34, 46 and 60 arginine residues. The longer polyarginines, R34, R46 
and R60, were toxic to cells at the experimental conditions (12.5 µM for 15 minutes) that 
worked well for the shorter peptides. Decreasing the concentration and incubation times 
made the cells more viable with the longer peptides. The cells were analyzed with 
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confocal microscopy after incubation. Confocal images show that cells incubated with R4 
do not have detectable fluorescence inside them (Fig 4.2a). Cells incubated with R9 
demonstrated high fluorescence intensity indicating efficient translocation (Fig 4.2c). The 
longer peptides, R34, R46 and R60, were also able to enter cells; however, the 
fluorescence associated with the cells was less intense compared to R9 (Fig 4.2d, e, f). 
These results are consistent with previous observations [7,11,12]. 
 
 
 
 
a)  b) c)
 
 
 
d)  e) f)
Figure 4.2: Confocal microscopy analysis of HeLa cells incubated with (a) R4, (b) TAT 
peptide, (c) R9, (d) R34, (e) R46, and (f) R60. The images show that R4 is 
unable to enter cells. TAT peptide and R9 enter cells efficiently. The longer 
peptides, R34, R46 and R60, are also able to enter cells but not as efficiently as 
TAT peptide or R9. 
 
We studied the interaction of the polyarginines with model membranes using 
SAXS. The diffraction results show that R4 with 20:80 DOPS:DOPE forms an inverted 
hexagonal phase with a coexisting lamellar phase (4.3a). The lattice constant of the 
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inverted hexagonal phase is 7.7 nm, with the pore size of ~3 nm. These results indicate 
that R4, like polylysine, generates negative mean curvature rather the negative Gaussian 
curvature. On the other hand, R9 induces negative Gaussian curvature. It forms the cubic 
Pn3m phase with the 20:80 DOPS:DOPE model membranes. It exhibits a similar phase 
behavior as the TAT peptide [6].  The longer arginine polymers, R34, R46 and R60, are also 
able to induce the Pn3m cubic phase but only over a much narrower range of peptide to 
lipid molar ratios (P/L) as compared to R9 or TAT peptide. The lattice parameter of the 
induced Pn3m cubic phase increases as the number of arginine residues increases (Fig 
4.3b). These results suggest that the ability of a peptide to generate negative Gaussian 
curvature may be used as an indicator for its transduction activity. 
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Figure 4.3: (a) SAXS data show that R4 induces an inverted hexagonal phase with 20:80 
PS:PE vesicles (bottom). The longer polyarginines form the cubic Pn3m 
phase. (b) The lattice parameter of the induced cubic phases increases with 
increasing number of arginine residues. 
 
 Arginine-rich cell penetrating peptides that are found in nature do not necessarily 
have all their arginine residues contiguous. Peptides such as penetratin or pVEC, have 
other amino acids separating the arginine rich domains. We use peptides with two R4 
domains separated by different lengths of polyethylene glycol (PEG) spacers to 
understand the effect of separation distance on transduction activity. The peptides used 
were RPEG-5, which has the R4 domains separated by 5 monomers of PEG, and RPEG-
27, where the R4 domains are separated by 27 monomers of PEG. The separation distance 
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between the R4 domains in these peptides is 1.5 nm for RPEG-5, and 4.6 nm for RPEG-
27. The synchrotron diffraction results for the interaction of these peptides with 20:80 
DOPE:DOPE model membranes is shown in fig 4.4. The results show that RPEG-27, 
which has the R4 domains separated by the largest distance, forms an inverted hexagonal 
phase with a coexisting lamellar phase. The lattice constant of the inverted hexagonal 
phase is similar to that induced by R4 only. The difference in the lamellar spacing in the 
RPEG-27 induced phase and the lamellar spacing in the R4 only lamellar phase is similar 
to the size of the PEG spacer. These results indicate that RPEG-27 essentially acts as 
unconnected R4 peptides, with the PEG spacer only swelling the membranes in lamellar 
phase. On the other hand, the peptide with the smaller PEG spacers, RPEG-5, induces the 
cubic Pn3m phase with 20:80 DOPS:DOPE. The diffraction peaks and the indexing for 
the two peptides are shown in fig. The lattice constant of the Pn3m phase for RPEG-5 is 
16.2 nm.  
 The above results show that peptides with the arginine rich domains separated by 
a PEG spacer approximately the size of amino acids (on the order of 1 nm), behave as a 
single long polyarginine molecule. However, peptides which have the arginine rich 
domains separated by PEG spacers about the thickness of the lipid bilayers (~ 4.5 nm) 
behave as independent short arginine peptides.  
 
 
 
 
  98
   
0.5 1.0 1.5 2.0 2.5 3.0 3.5
 
R4
 
 
R-PEG27
R-PEG5
I
q nm-1
 
 
 
1.5 nm 
 
 
4.6 nm  
 
 
 
Figure 4.4: SAXS data for peptides with two R4 domains separated by PEG spacers.     
R-PEG27 forms coexisting lamellar and inverted hexagonal phases while  
R-PEG5 induces the cubic Pn3m phase. Schematics of the peptides shown 
on the right. 
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4.3.2 Significance of gaussian membrane curvature for pore formation and other 
cellular processes 
 The formation of a pore in a membrane requires the generation of negative 
Gaussian curvature (K<0). The Gaussian Curvature, K, at a point on the membrane is the 
product of the two principle axes of curvature at that point.  Therefore, K<0 implies the 
principle axes of curvature at a given point must curve in opposite directions, so that the 
membrane is locally shaped like a saddle (fig 4.5a).  This is the type of curvature seen 
objects with holes, for example a torus: the ‘hole’ of the torus is composed of regions 
with saddle-shaped curvature. In contrast, objects such as spheres have no holes, and 
have K>0 everywhere on their surface (fig 4.5b).  
In a more general compass, it can be seen that negative Gaussian curvature is 
broadly enabling. While negative Gaussian curvature is topologically necessary for pore 
formation it can be seen in other processes.  From fig 4.5, it can be seen that generation 
of negative Gaussian membrane curvature is a necessary condition for the dimples for 
caveoli-based endocytosis, for the cytoskeleton-driven protrusions in macropinocytosis, 
as well as for pore formation. The Gauss-Bonnet theorem shows that if pores do not 
form, the net change in the global Gaussian curvature of the membrane is zero, i.e. 
Δ∫K·dA = 0:  If one region of the membrane develops positive Gaussian curvature then 
some other region will develop negative Gaussian curvature to exactly compensate for 
the distortion.  Examples of this balance of curvatures constrained by topology can be 
seen in proposed types of TAT entry mechanisms.  The invaginations in a cell’s plasma 
membrane surface during endocytosis display negative Gaussian curvature along the rim 
of the enclosure while the ‘pocket’ is sphere-shaped with positive Gaussian curvature.  
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For cellular uptake processes such as macropinocytosis, the positive Gaussian curvature 
at the tip of protrusions is countered by the negative Gaussian curvature found at the base 
of the extension.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Examples of (a) negative Gaussian curvature and (b) positive Gaussian 
curvature. The former is saddle shaped and found in objects with holes such 
as a donut. The latter is found on objects like spheres or ellipsoids, and do 
not have holes. Negative Gaussian curvature is topologically necessary for 
the formation of (c) membrane pores, (d) membrane dimples or 
invaginations (such as those in endocytosis), and (e) membrane protrusions 
(such as those in macropinocytosis). 
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4.3.3 Role of cholesterol 
Cholesterol is present in eukaryotic membranes in significant amount. The 
structure of cholesterol consists of four fused carbon rings. They make the hydrophobic 
part of cholesterol very rigid. The hydroxyl group is the polar part of cholesterol. The 
large hydrophobic tail and the small hydrophilic head give cholesterol its negative 
intrinsic curvature while making it highly insoluble in water. Cholesterol is 
accommodated rapidly in membranes and forms liquid-ordered domains, called ‘lipid 
rafts’. High cholesterol membrane content has been shown to accompany receptor 
independent endocytosis mechanisms implicated in cell-penetrating peptide uptake.  
In order to understand the role of cholesterol in TAT peptide uptake, we studied 
the interaction of TAT peptide with membranes containing cholesterol. We fixed the 
DOPS content at 20% by weight and varied the amounts of DOPE, DOPC and 
cholesterol. The phase diagram of TAT peptide-membrane interaction with increasing 
cholesterol content is shown in fig 4.6. For membranes that do not contain cholesterol, 
the cubic Pn3m phase is observed only with a high amount of DOPE (>70%). However, 
adding cholesterol decreases the amount of DOPE required to form the cubic Pn3m 
phase. These results indicate that the presence of cholesterol enhances the ability of cell-
penetrating peptides to generate the Pn3m cubic phase.  
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Figure 4.6: Phase diagram of TAT-PTD with PS/PE/PC/Cholesterol membranes show 
that addition of cholesterol decreases the threshold concentration of DOPE 
required to form the cubic Pn3m phase. 
 
The x-ray data show a strong dependence of the phase behavior on membrane 
lipid composition.  The phase diagram indicates that the Pn3m cubic phase is generated 
by TAT peptide in membranes enriched with negative intrinsic curvature lipids (c0 < 0), 
like PE and cholesterol.  Substitution with PC (c0 = 0) makes the intrinsic curvature of the 
membrane monolayers less negative which results in the loss of the negative gaussian 
curvature-rich Pn3m phase.  Moreover, direct translocation of TAT peptide into the 
interior of giant unilamellar vesicles (GUVs) was shown to depend on a threshold amount 
of negative intrinsic curvature lipid, PE.   
 Formation of a hydrophilic or toroidal pore in a membrane results in a change in 
Gaussian curvature in the membrane.  From the Gauss-Bonnet theorem it can be shown 
that the change is given by Δ∫K·dA = -4π.  It follows that the free energy change from 
pore formation is E = κG ∫K·dA = -4πκG, where κG is the Gaussian curvature modulus of 
the bilayer.  It can be shown [24]: 
2 4m m mG G ocκ κ κ= − δ  
Here κGm (< 0, from the lateral stress profile of a membrane monolayer [25]) is the 
Gaussian curvature modulus of the monolayer, κm (>0) is the monolayer bending 
modulus, and δ (>0) is the distance from the middle of the bilayer to the monolayer pivot 
point.   
 Typically the negative value of the monolayer Gaussian curvature 
modulus ensures that κG likewise remains negative preventing pore formation.  However, 
negative intrinsic curvature lipids such as PE and cholesterol decrease com, the intrinsic 
curvature of the membrane monolayer, shifting the bilayer Gaussian curvature modulus 
toward positive values. The decreased energetic barrier to changes in membrane topology 
toward porous phases enhances the negative Gaussian curvature generation abilities of 
cell penetrating peptides thereby enhancing their transduction ability. 
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4.3.4 Effect of transport inhibitors on cellular uptake 
Lipid-raft mediated endocytosis processes, like macropinocytosis and caveolae-
mediated endocytosis, have been implicated in the membrane transduction mechanism of 
cell-penetrating peptides [16,17,26].  Macropinocytosis involves the formation of large 
endocytotic vesicles (macropinosomes) of irregular size and shape, generated by actin-
driven envagination of the plasma membrane. Caveolae are small, hydrophobic 
membrane microdomains, rich in cholesterol and glycosphingolipids that trap membrane-
associated ligands and bud off the membrane, forming caveosomes [27]. Transport 
inhibition experiments were performed to examine the cellular uptake of TAT peptide in 
the presence of specific inhibitors. The nuclei of the HeLa cells were stained with DAPI. 
The cells were pretreated with cytochalasin D or nystatin, chemicals that inhibit 
macropinocytosis and caveolae-dependent endocytosis respectively.  The pretreated cells 
were then incubated with fluorescently-labeled TAT peptide at 12.5 uM for 15 minutes.  
Figure 4.7 shows the representative confocal images of the HeLa cells. 
Fluorescence signal was observed throughout the control cells (cells not treated with 
transport inhibitors), indicating that the TAT peptide has crossed the cell membrane (Fig 
4.7a). While treating the cells with nystatin had a negligible effect (Fig 4.7b), 
cytochalasin D significantly reduced the uptake of TAT peptide (Fig 4.7c). Similar results 
are obtained when the HeLa cells are incubated with R9 (Fig 4.7d, e, f). These results 
indicate that macropinocytosis is important for TAT transduction.  
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Figure 4.7: Confocal microscopy images of HeLa cells incubated with TAT peptide (top 
row) and R9 (bottom row). (a) & (d) Control cells. (b) & (e) Cells pretreated 
with nystatin. (c) & (f) Cells pretreated with cytochalasin D.  
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4.3.5 TAT peptide induced reorganization of cytoskeleton 
 The cellular uptake of TAT peptide is reduced when the cells are treated with 
cytochalasin D, an inhibitor of actin polymerization. This implies an important role for 
actin polymerization. Actin is one of the principal structural proteins in eukaryotic cells. 
The actin cytoskeleton dynamically maintains the structural integrity of the plasma 
membrane and plays important roles in a number of membrane-associated events, such as 
cell adhesion, cell motility, and regulation of integral membrane protein distributions. 
This versatility is afforded by actin’s ability to dynamically adjust its degree of 
polymerization from monomeric G-actin (35 Å by 55 Å by 55 Å) to polymeric F-Actin, 
which is a linear chain of G-actin subunits. The polymerization process is reversible and 
depends on the ionic strength of the solution. F-Actin filaments are helical and very stiff; 
with a persistence length of ≈ 10 µm. Actin has an approximate average linear charge 
density of 1e-/2.5Å at pH 7. In the presence of multivalent cations, F-actin filaments 
condense into close-packed bundles [28].  
 Small angle X-ray diffraction pattern shows that when TAT peptide is complexed 
with F-actin, it condenses the actin filaments into close-packed bundles (Fig 4.8a, top). 
Two correlation peaks are observed at q = 0.83 nm-1 and 1.34 nm-1. The ratio of the peak 
positions differs slightly from that expected for an exact hexagonal lattice. This 
diffraction pattern is similar to the pattern observed when F-actin is condensed by high 
concentration of divalent Ba2+ ions [29]. The same diffraction is observed when TAT 
peptide is complexed with the G-actin monomers (Fig 4.8a, bottom). This indicates that 
the TAT peptide can not only condense actin filaments into bundles but also polymerize 
actin monomers.    
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 It is known that reorganization of the cytoskeleton drives membrane deformations 
during processes like cell motility and endocytosis. Polymerization of actin filaments and 
microtubules in giant unilamellar vesicles (GUV) show that membrane curvature 
fluctuations can influence formation of protrusions from the protein network [30,31].  We 
have seen that the TAT peptide can induce negative Gaussian curvature in membranes as 
well as polymerize and condense actin. Now we look at the effect of TAT peptide on 
spherical GUVs with encapsulated evolving cytoskeleton.  
 The GUVs encapsulate monomeric G-actin and Rh-phalloidin which specifically 
binds to filamentous F-actin. When a multivalent salt, like MgCl2, is added to the 
solution, the Mg2+ ions pass through the Calcium ion-channels in the membrane and 
induce polymerization of actin and promote the formation of a network of F-actin 
bundles. However, this does not deform the membrane and the vesicle remains spherical 
(Fig 4.8b). The TAT peptide has a dual effect when it is added to the vesicles. It not only 
changes the curvature of the membrane, but also enters the vesicle and encourages actin 
bundling. This deforms the vesicle and induces blebbing or fingering which are stabilized 
by the encapsulated and growing actin network (Fig 4.8c, d). In some cases, the actin 
network aligns and grows in a certain orientation deforming the spherical vesicle into an 
elongated structure (Fig 4.8e). These results indicate that the TAT peptide can enhance 
membrane deformation and cytoskeleton reorganization necessary for endocytotic 
processes.   
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Figure 4.8: (a) SAXS data show that the TAT peptide condenses F-actin filaments into 
close-packed bundles (top).  It also polymerizes and condenses G-atin 
monomers (bottom). (b) Addition of MgCl2 to G-actin encapsulated GUVs 
induces polymerization and formation of actin network without any 
accompanying deformation of vesicle. (c) & (d) Addition of TAT peptide 
induces blebbing or fingering stabilized by the growing actin network. (e) 
Growth of actin network leads to elongated vesicles in some cases. 
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4.3.6 Effect of cargo size 
The size of the cargo attached to the TAT peptide appears to determine the 
mechanism of uptake. It has been shown that complexes or fusions of TAT with large 
20 nm quantum dots or proteins (> 50 amino acids) enter cells primarily through an 
endocytotic, vesicle-associated pathway whereas a small peptide (< 50 amino acids) 
cargo can transduce cells through an additional, non-endocytotic pathway. In addition, 
the specific endocytotic pathway also appears to depend on the cargo size. It was 
observed that when fluorescent beads attached to TAT peptide are less than 200 nm in 
diameter, cellular uptake is primarily through clatharin-mediated endocytosis. As the size 
of the beads increases the mode of uptake becomes increasingly caveolae-mediated with 
the caveolae pathway dominating for beads of 500 nm in diameter [1].  
We look at the effect of cargo size on the ability of TAT peptide to enter giant 
vesicles. For the bulky cargo we use PLA nanoparticles roughly 30 nm in diameter. 
These naoparticles are modified to have maleimide groups on the surface which are used 
to conjugated TAT peptides with a cysteine residue at the end. The nanoparticles are 
stained with Cy5 dye. As we have seen earlier, when TAT peptide (with no bulky cargo 
attached) is added to vesicles containing PE lipids above a certain threshold, it enters the 
vesicles and the peptide concentration equilibrates across the membrane (Fig 4.9a). When 
the PLA nanoparticles, with no conjugated TAT peptide, are added to the same vesicles, 
they are unable to enter the vesicles and remain equally distributed in the solution (Fig 
4.9b). Nanoparticles conjugated to TAT peptide are also unable to enter vesicles; 
however, they aggregate around the periphery of GUVs, causing an enhancement of 
fluorescence intensity at the lipid bilayer (Fig 4.9c). These results suggest that although 
  110
large nanoparticles conjugated to TAT peptide are unable to enter lipid vesicles, the TAT 
peptide anchors the nanoparticles to the membrane.    
 
b)a)  c) 
 
 
 
 
 
Figure 4.9: (a) Rhodamine-tagged TAT peptide (false-color red) applied to the exterior 
of PS:PC:PE 20:40:40 GUVs crosses the membrane with the vesicle interior 
having the same brightness as the outside, showing that the Rh-TAT 
concentration has equilibrated on both sides of the membrane. (b) Cy5-
tagged PLA nanoparticles (blue) never enter the GUVs and remain 
distributed outside. (c)  Cy5-tagged PLA nanoparticles conjugated to TAT 
peptide (blue) aggregate around the periphery of GUVs, causing an 
enhancement of fluorescence intensity at the lipid bilayer.  
 
  
4.3.7 Mechanism for transduction 
We believe the above results can explain how a simple molecule like the TAT 
peptide can utilize various endocytotic and non-endocytotic mechanisms for cellular 
transduction. When the TAT peptide approaches the cellular membrane, it can interact 
with either a receptor, like heparin sulfate, or directly with the membrane. If the TAT 
peptide interacts with heparin sulfate, it binds to it with high affinity and gets internalized 
by endocytosis. If the TAT peptide does not bind to any receptor but interacts directly 
with the lipid membrane, it induces negative Gaussian curvature locally. This type of 
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curvature is a necessary condition for the dimples for caveoli- or clatharin-based 
endocytosis, for the cytoskeleton-driven protrusions in macropinocytosis, as well as for 
pore formation. The mechanism by which TAT peptide generates such curvature has 
been explained earlier, and involves the guanidinium group forming bidentate hydrogen 
bonds. Presence of negative intrinsic lipids, like DOPE and Cholesterol, enhance the 
ability of the peptide to generate negative Gaussian curvature. If the cargo attached to the 
TAT peptide is small enough, it can be directly translocated into the cells. However, 
bulky cargoes get anchored to the membrane by the TAT peptide (Fig 4.10). Since the 
TAT peptide generates negative Gaussian curvature, it makes it easier for the cell to 
internalize the attached bulky cargo by one of the various endocytosis processes. In 
addition, the TAT peptide encourages actin polymerization and bundling, thereby, 
enhancing macropinocytosis.   
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Figure 4.10: Schematic showing mechanism of transduction for TAT peptide coupled to 
bulky cargos. The TAT peptide lands on the membrane, generates negative 
Gaussian curvature and anchors the cargo. Internalization occurs via one of 
the various endocytosis processes including macropinocytosis.   
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4.4 Summary 
Arginine rich cell-penetrating peptides are short cationic peptides capable of 
traversing the plasma membranes of eukaryotic cells.  While successful intracellular 
delivery of many biologically active macromolecules has been accomplished using these 
peptides, their mechanisms of cell entry are still under investigation. We used 
synchrotron small angle x-ray scattering (SAXS) to study the interactions of arginine rich 
peptides with model cell membranes and find that the transduction activity correlates 
with induction of negative Gaussian (‘saddle-splay’) membrane curvature. The negative 
Gaussian membrane curvature is broadly enabling and its induction can lower the free 
energy barriers for a range of different entry mechanisms, such as direct translocation as 
well as endocytotic pathways. Moreover, the peptides have strong electrostatic 
interactions with different components of the cell besides the cell membrane, in ways that 
contribute to their activity. Finally, we connect the observations with a mechanism that 
explains how a relatively simple molecule, like the TAT peptide, facilitates mechanisms 
as different as direct entry and the multiple endocytotic mechanisms. 
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CHAPTER 5 
INORGANIC MERCURY DETECTION AND CONTROLLED 
RELEASE OF CHELATING AGENTS FROM ION-
RESPONSIVE PEG-LIPOSOMES 
 
5.1 Introduction 
Liposomes are assemblies of lipid molecules in the form of closed 
spherical bilayers.  They have been used extensively for drug delivery 
applications. Liposome based delivery systems can be used to isolate a bioactive 
agent, so as to direct the agent away from certain tissues and to deliver the agent 
to other tissues. Since the lipid bilayer separates the encapsulated content from the 
external environment, efficient encapsulation of a broad range of cargo is 
possible.[1,2] It has been shown that inorganic mercury binds to 
phosphatidylethanolamine (PE) lipid headgroups strongly and can reorient them 
(Figure 1A inset).[3] PE lipids have negative intrinsic curvature; hence, liposomes 
of 100% PE are not possible. However, we can form and stabilize vesicles of such 
lipids by incorporating polymeric bulky headgroups, like polyethylene glycol 
(PEG), on the hydrophilic side. We hypothesized that such PE-based PEG-
liposomes may be used to develop a mercury sensing and controlled release 
platform. 
 
Mercury exposure has been linked to a number of health problems, such as 
damage to the central nervous system, endocrine system, brain, kidney and fetus 
development.[4] Since inorganic mercury is found in water, soil, food sources, as 
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well as a broad range of environments, there is a substantial need for both 
sensitive detection and efficient detoxification of mercury just like we do for 
sensing other biologically important metal ions.[5-9] To meet the need, a number 
of mercury sensors have been developed based on small organic molecules,[10-
19] oligonucleotides,[20,21] conjugated polymers,[22] foldamers,[23], 
micelles,[24] genetically engineered cells,[25], membranes,[26] electrodes,[27] 
enzymes,[28] antibodies,[29] proteins,[30,31] DNAzymes,[32,33], functionalized 
nanotubes, [34] and nanoparticles.[35,36] Despite the progress of mercury 
detection in organic solvents, there remains a need for sensors with high 
sensitivity and selectivity that can detect mercury in water,[11,12,17,37-41] and 
no single platform can detect and detoxify mercury at the same time. Moreover, 
the distribution of mercury can be location- and time-specific, a systemic dose of 
detoxifying agents can be inefficient in dealing with various concentrations of 
mercury, while a large dose can potentially lead to undesirable side effects.   
 
In collaboration with Mehmet Yigit and Prof. Yi Lu, we developed a novel 
liposome-based system that can detect and respond to the presence of mercury 
with a concentration as low as 10 nM, the maximum contamination level defined 
by the U.S. Environmental Protection Agency for mercury in drinking water. In 
particular, we were able to modulate the release profile of Hg chelators by the 
local concentration of Hg so that more chelators are released in regions with high 
concentration Hg and low or no chelators are released in regions of low 
concentration. This ‘budgeted’ release profile will be particularly useful in 
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situations in which the local levels of Hg contamination vary, or if such 
contamination is time-dependent. 
 
5.2 Experimental section 
5.2.1 Materials 
The lipids 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), and 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-n-methoxy(polyethyleneglycol)-
2000](ammonium salt) (PEG-PE) were purchased from Avanti Polar Lipids. 
Stock solutions of lipids in chloroform at 30 mg/ml were freshly prepared. 
Column buffer was prepared by addition of 24 ml of 500 mM HEPES buffer at 
pH 7.4 and 15 ml of 2 M NaCl into 160 ml of distilled water. 1 mM, 100 μM and 
10 μM stock solutions of Hg(ClO4)2 were prepared. 200 mM and 1 mM stock 
solution of divalent metal ions were prepared for further use. 
 
5.2.2 Liposome preparation 
The PEG-PE and DOPE were mixed at the 20% w/w ratio. The solution 
was dried under N2 and desiccated under vacuum overnight. The dried lipids are 
rehydrated with 1 ml of 50 mM of fluorescein in 100 mM of NaCl and 50 mM of 
HEPES buffer at pH 7.4. The hydrated mixture is incubated at 37 °C for one day. 
The resultant solution is extruded 11 times in a mini-extruder through 1 μm 
polycarbonate membrane. The resulting vesicles are purified by PD-10 desalting 
column against column buffer. 1300 μl of liposome solution is collected from PD-
10 column. The liposome solution is diluted to 4500 μl in column buffer. 
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5.2.3 Detection of mercury by fluorescence 
2 μl of stock solution of 1, 2.5, 5, 10 or 100 μM of Hg(ClO4)2 was added 
into 200 μl of fluorescein encapsulated liposomes for detection of final 
concentration of 10, 25, 50, 100 or 1000 nM Hg2+. The fluorescence change with 
the addition of inorganic mercury is monitored by fluorimeter (λex = 495 nm and 
λem = 520 nm) over 15 minutes using disposable glass cuvettes. In order to check 
the effect of other divalent metal ions, 2 μl of stock solution of various 
concentrations of metal salts was added into 200 μl of fluorescein encapsulated 
liposomes. The change in fluorescence is monitored using the same parameters in 
monitoring the effect of Hg2+. The fluorescent measurements are performed in 
triplicate. 
 
5.2.4 Encapsulation of meso-DMSA and fluorescein in liposomes 
The DOPE and PEG-PE were mixed at the four to one ratio, dried under 
N2 and desiccated under vacuum overnight. The dried lipids are rehydrated with 1 
ml of 50 mM fluorescein with 0, 100, 1000 or 2000 μM meso-DMSA in 100 mM 
of NaCl and 50 mM of HEPES buffer at pH 7.4 for in vitro experiments. The 
dried lipids are rehydrated with 1 ml of 2 μM meso-DMSA in 100 mM of NaCl 
and 50 mM of HEPES buffer at pH 7.4 for HeLa cell experiments. The hydrated 
mixture is incubated at 37 °C for one day. The resultant solution is extruded 11 
times in a mini-extruder through 1 μm polycarbonate membrane. The resulting 
vesicles are purified by PD-10 desalting column against column buffer. 1300 μl of 
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liposome solution is collected from PD-10 column. The liposome solution is 
diluted to 4500 μl in column buffer. 
 
5.2.5 HeLa cell experiments 
HeLa cells are cultured following ATCC’s recommendation, in Eagle’s 
Menimum Essential Medium, supplemented with 100 units/mL aqueous penicillin 
G, 100 μg/mL streptomycin, and 10% fetal bovine serum.The HeLa cells were 
grown in 96-well plates with medium at concentrations to allow 70% confluence 
in 24 h. At the experiment day, cells were washed with PBS buffer and incubated 
with prewarmed Opti-MEM medium (phenol red reduced) for 30 minutes at 37 
oC. After the addition of different formulations of liposomes (with or without 
meso- DMSA (2μM, 80μL)), cells was incubated for 8 hours and then washed 
with 100 μL/well PBS twice. Cells were further treated with 0, 0.2, 0.4, 0.6, 0.8 or 
1.0 μM final concentrations of Hg using stock solution of 20, 40, 60, 80 or 100 
μM of Hg(ClO4)2 in prewarmed fresh growth medium for 48 h. Cell viability was 
assessed colorimetrically with the MTT reagent (Sigma-Aldrich) following the 
standard protocol provided by the manufacturer. The absorbance was read with a 
microplate reader at 570 nm. 
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5.3 Results and discussion 
 PEG-liposomes, encapsulating both fluorescent molecules and mercury-
specific chelators, were designed to rupture in the presence of mercury, thus 
releasing the encapsulated fluorophores and the chelators. Since the self-
quenching of the fluorophores inside of the liposome is reversed upon liposome 
rupture, the fluorescent signal increases, thereby providing a read-out of the 
release profile (Figure 5.1a). Importantly, as the chelators are released to reduce 
the concentration of free mercury (Figure 5.1b), the release of chelators is down 
regulated, so that the PEG-liposomes can be maximally available to interact with 
free mercury elsewhere. 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Interaction of inorganic mercury with a) fluorescein encapsulated 
DOPE liposomes and b) meso-DMSA and fluorescein encapsulated 
DOPE liposomes. Green and orange circles represent fluorescein and 
meso-DMSA, respectively. Enlarged areas show lipid molecules on 
the liposome surface and their interaction with Hg2+ that destabilizes 
liposomes. 
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To demonstrate the rupture of liposomes in the presence of Hg2+, 
liposomes were prepared using 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE) and PEG-PE (PEG MW 2000Da) as the building blocks. Liposomes 
consisting of 100% DOPE are not stable due to the negative intrinsic curvature of 
PE lipids. However, we found that by incorporating 20% w/w of PEG we were 
able to achieve stable liposomes. Fluorescein was encapsulated in the liposome 
with a concentration of 50 nM, which is sufficiently high to ensure fluorescence 
self-quenching and detection. The interaction of mercury ions with DOPE 
headgroups, and the resultant induced reorientation of the headgroups, can in 
principle lead to rupture of the vesicles, thereby releasing and unquenching the 
fluorescein. When 1 µM of Hg(ClO4)2 was added to the liposomes, a significant 
increase in the fluorescence was indeed observed (Figure 5.2a). The fluorescein 
release at this concentration of mercury is determined to be the maximum by 
comparing it to the fluorescein release by Triton-X (a detergent), which should 
rupture all lipid vesicles in the solution. To further quantify this effect, different 
amounts of Hg2+ were added into the liposome solution and the change in 
fluorescence spectra was monitored over a 15 minutes time period. The 
fluorescence increase with 10, 25, 50, 100 nM and 1 µM Hg2+ was determined as 
20.66 ± 6.88 %, 24.66 ± 7.54 %, 59.8 ± 19.74 %, 74.28 ± 5.85 % and 97.83 ± 
3.05 %, respectively. As shown in Figure 5.2b, fluorescence increased with 
increasing concentration of Hg2+, which is consistent with the hypothesis that 
mercury is the inducing agent for liposome rupture and fluorescein release. At 10 
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nM of Hg2+, the maximum contamination level defined by the US EPA, the 
system can still display signal above the background (Figure 5.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 a) Fluorescence spectra of fluorescein encapsulated liposomes before 
(black) and after (red) addition of 1 µM Hg2+, λex=495 nm, b) Time-
dependent fluorescence change after addition of 10, 25, 50, 100, 
1000 nM Hg2+ or 1 µM Hg2+ chelated with meso-DMSA (1 µM + 
meso-DMSA). 
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To test whether Hg2+-lipid interaction can be used to make ion-responsive 
liposomes for the ‘budgeted’ release of chelating agents, meso-2,3-
dimercaptosuccinic acid (meso-DMSA), a molecule routinely used in clinic for 
the treatment of mercury exposure, was encapsulated in the liposome in order to 
chelate mercury.  Meso-DMSA is one of the most commonly used chelators as it 
is water-soluble, odorless, stable and nearly non-toxic.[42] It binds to the 
inorganic mercury and forms non-toxic metal-chelator complex.[43-46] To test 
the efficiency of meso-DMSA chelation, we incubated Hg2+ with meso-DMSA for 
five minutes and then added it to the fluorescein-encapsulated liposomes for a 
final concentration of 1 µM of Hg2+. In contrast to high the fluorescence intensity 
(97.83 + 3.05 %) at the same concentration of Hg2+ in the absence of meso-
DMSA, the fluorescence intensity remained unchanged in the presence of meso-
DMSA (Figure 5.2b, 1µM + meso-DMSA). This experiment indicates that the 
mercury ions that bind to meso-DMSA can no longer interact with new lipid 
headgroups and therefore do not break up liposomes that encapsulate additional 
chelators. 
 
In order to quantify the detection and budgeted chelation of Hg2+ 
simultaneously, we encapsulated 50 mM fluorescein with 0, 100, 1000 or 2000 
µM meso-DMSA in the liposomes. The liposomes were then incubated with 1µM 
Hg2+ for 15 min.  As shown in the inset of Figure 5.3, the concentration of meso-
DMSA is inversely correlated with the fluorescence intensity inside of the 
liposomes.  This result indicates that when the liposomes interact with the 
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mercury ions, some liposomes rupture and release the encapsulated dye and meso-
DMSA. The released dye results in the increase in fluorescence intensity while 
the released meso-DMSA binds to the mercury ions; the resulting complex is 
unable to rupture the liposomes. As the concentration of meso-DMSA increases, 
fewer liposomes are ruptured resulting in smaller increase in fluorescence. This 
result further demonstrates that the liposomes comprise a single delivery platform 
that can be used for both Hg2+ detection and efficient Hg2+ chelation via the 
budgeted release of meso-DMSA from ion-responsive liposomes. Clearly, the rate 
of liposome rupture depends on the Hg2+ concentration. This important property 
allows for tuning the response of these liposomes by encapsulating different doses 
of the chelators. Since only a fraction of the liposomes are ruptured in this 
controlled chelation scheme, only as much chelators are released as necessary, 
leaving the rest intact for further detection and chelation of mercury 
contamination. 
It is known that different ions can also interact with lipids, and potentially 
lead to adventitious interactions with liposomes. To test selectivity of the present 
system for mercury, we added 10 µM of different divalent metal ions and 1 mM 
Mg2+ and Ca2+ to the system. The increase in the fluorescence upon addition of 10 
μM of essentially all other divalent metal ions and 1 mM of Ca2+ or Mg2+ is 
drastically lower compared to the increase on addition of only 10 nM of Hg2+ (see 
Figure 5.3). This result suggests that the system in not only sensitive but also 
selective to Hg2+. 
 
 128
  
 
 
 
 
 
 
 
 
Figure 5.3 Fluorescence change in fluorescein encapsulated liposomes with 
various divalent metal ions and different concentrations of Hg2+. 
Inset: fluorescence increase with fluorescein and various 
concentration of meso-DMSA encapsulated DOPE liposomes with 1 
µM Hg2+. The [Hg] indicates mercury chelated with meso-DMSA. 
Experiments are performed in triplicate. 
 
To find out if such selectivity is maintained not only when individual 
metal ion is tested, as shown in Figure 5.3, but also when mixtures of metal ions 
are used, we compared the increase in fluorescence intensity between the 
liposome encapsulating fluorescein alone and the liposome encapsulating both 
fluorescein and meso-DMSA in the presence of 1μM Hg2+ and 10 μM Mn2+, Cd2+, 
Ba2+, Co2+ or Cu2+. As shown in Figure 5.4, the liposomes containing fluorescein 
and meso-DMSA has significantly less fluorescent increase than the liposomes 
containing only fluorescein, suggesting that Hg2+ effect are maintained in the 
presence of excess of other metal ions. 
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Figure 5.4: Fluorescence change in 50 mM fluorescein encapsulated (light gray) 
or 50 mM fluorescein and 3 mM meso-DMSA encapsulated 
liposomes with 10 µM Mn2++ 1 µM Hg2+,10 µM Cd2++ 1 µM Hg2+, 
10 µM Ba2++ 1 µM Hg2+, 10 µM Co2++ 1 µM Hg2+ or 10 µM Co2++ 
1 µM Hg2+. Experiments are performed in triplicate. 
 
After demonstrating the controlled and budgeted release of a Hg2+ chelator 
in vitro, we assessed whether this approach can be used in a biological systems.  
First, we utilized the HeLa cells in this study and checked the viability of the 
HeLa cells in the presence of Hg2+ at a concentration of 0, 0.2, 0.4, 0.6, 0.8 and 
1.0 μM. As shown in the Figure 5.5a, the cell viability decreased dramatically to 
35.7% in the presence of 0.2 μM Hg2+ and further decreased to 24.0 % in the 
presence of 0.4 μM Hg2+, which confirmed the toxicity of Hg2+ to the cells. 
Incubating the HeLa cells with liposomes without any chelator resulted in almost 
identical toxicity profiles as the cells in the absence of liposome, indicating that 
the liposomes cannot interact with Hg2+ to reduce its toxicity. In contrast, when 2 
μM meso-DMSA-containing liposome was incubated with the HeLa cells, 
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substantially improved viabilities were observed.  The cell viabilities improved 
56.8% and 43.1% when 2 μM meso-DMSA was added to the cell culture media 
containing 0.2 and 0.4 μM Hg2+, respectively, than those without meso-DMSA 
(Figure 5.5a). The cell viability did not improve beyond 0.6 μM of Hg2+, probably 
due to the limitation of amount of 2 μM meso-DMSA that can be encapsulated 
into liposome and their incomplete release. To provide further evidence for 
dosage-dependence protection, we carried out the same experiment in the 
presence of a constant concentration of 0.4 μM Hg2+ and used HeLa cells that 
were pretreated with increasing concentrations of either liposome alone (LP) or 
liposome with meso-DMSA (LP-meso-DMSA).  As shown in Figure 5.5b, 
different concentrations of liposome-treated cells without chelator inside have 
little effect on cell viability, while increasing concentrations of liposome 
encapsulated meso-DMSA resulted in higher cell viability (from 24.0% to 
49.4%), indicating the effects of controlled and budgeted release of a Hg2+ 
chelator in cellular environment. 
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Figure 5.5: HeLa cells viability assays in the presence of different Hg2+ 
concentrations. a), HeLa cells alone (Hg), HeLa cells initially treated 
with liposomes (LP +Hg), or with liposomes containing meso-
DMSA (LP- meso-DMSA + Hg); b) 0.4 μM Hg2+, were first treated 
with liposomes loaded with meso-DMSA (LP- meso-DMSA + Hg), 
or with no meso-DMSA (LP +Hg). Cell viability measured at Day 2 
of liposome/cell incubation by MTT cytotoxicity assays. 
 
 132
5.4 Conclusion 
Mercury is a highly toxic and widespread pollutant in the environment.  
Therefore, the strategy or the system that allows for both sensitive detection and 
efficient detoxification of mercury is in great demand.  For this reason a number 
of mercury sensor related papers have been published recently. However, no 
single platform can detect and detoxify mercury at the same time.  More 
importantly, since the distribution of mercury can be location- and time-specific, a 
single dose of mercury detoxification agent may be inefficient in dealing with 
various concentrations of Hg, and too high a concentration of the agent can 
potentially lead to side-effects. 
We have demonstrated a multiple-use, liposome based system that can 
simultaneously detect and detoxify inorganic mercury, both in vitro and in HeLa 
cells, by controlled and budgeted release of both a fluorophore for sensing and a 
chelating agent for detoxification. This system is highly selective for mercury, 
and is able to detect mercury as low as 10 nM, the maximum contamination level 
defined by the US EPA. This budgeted release profile will be particularly useful 
in situations where the local levels of Hg contamination vary in a location- and 
time- dependent manner. 
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